UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549



FORM			10-Q

(Mark One)


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, ~~2021~~2022


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-31321



NAUTILUS, INC.
(Exact name of Registrant as specified in its charter)


Washington						94-3002667
(State or other jurisdiction of incorporation or organization)						(I.R.S. Employer Identification No.)

17750 S.E. 6th Way

Vancouver, Washington 98683

(Address of principal executive offices, including zip code)

(360) 859-2900

(Registrant's telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, no par value	NLS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [x] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

[ ]

Accelerated Filer

[x]

Non-accelerated filer

[ ]

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No [x]

~~Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:~~

The number of shares outstanding of the registrant's common stock as of August ~~6, 2021~~5, 2022 was ~~30,930,700~~ 31,610,130 sh~~shares.~~ares.

NAUTILUS, INC.

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED JUNE 30, ~~2021~~2022


	PART I
Item 1.	Financial Statements	1
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	1821
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	2934
Item 4.	Controls and Procedures	2934

	PART II
Item 1.	Legal Proceedings	3035
Item 1A.	Risk Factors	3035

Item 6.	Exhibits	3036
Signatures		3137

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

NAUTILUS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(~~Unaudited and~~ in thousands)

As of
June 30, 2021 March 31, 2021
Assets
Cash and cash equivalents $ 25,218 $ 38,441
Restricted cash 1,339 1,339
Available-for-sale securities 56,264 73,448
Trade receivables, net of allowances of $1,311 and $1,177 98,160 88,657
Inventories 111,132 68,085
Prepaids and other current assets 15,650 25,840
Income taxes receivable 9,500 0
Total current assets 317,263 295,810
Property, plant and equipment, net 24,718 24,496
Operating lease right-of-use assets 25,662 19,108
Other intangible assets, net 9,350 9,365
Deferred income tax assets, non-current 3,068 2,144
Other assets 2,325 3,307
Total assets $ 382,386 $ 354,230
Liabilities and Shareholders' Equity
Trade payables $ 114,602 $ 98,878
Accrued liabilities 14,515 19,627
Operating lease liabilities, current portion 4,706 3,384
Warranty obligations, current portion 8,191 7,243
Income taxes payable, current portion 845 5,709
Debt payable, current portion, net of unamortized debt issuance costs of $83 and $83 3,125 3,000
Total current liabilities 145,984 137,841
Operating lease liabilities, non-current 23,221 17,875
Warranty obligations, non-current 1,593 1,408
Income taxes payable, non-current 3,805 3,657
Other non-current liabilities 606 607
Debt payable, non-current, net of unamortized debt issuance costs of $215 and $236 10,296 10,297
Total liabilities 185,505 171,685
Commitments and contingencies (Note 15) 0 0
Shareholders' equity:
Common stock - 0 par value, 75,000 shares authorized, 30,794 and 30,576 shares issued and outstanding 2,411 2,176
Retained earnings 194,408 180,524
Accumulated other comprehensive income (loss) 62 (155)
Total shareholders' equity 196,881 182,545
Total liabilities and shareholders' equity $ 382,386 $ 354,230


	As of
	June 30, 2022		March 31, 2022
	(unaudited)
Assets
Cash and cash equivalents	$	7,311	$	12,872
Restricted cash	1,339		1,339

Trade receivables, net of allowances of $912 and $598	27,450		61,454
Inventories	103,932		111,190
Prepaids and other current assets	11,979		14,546
Other current assets - restricted, current	3,887		3,887
Income taxes receivable	1,721		1,998


Total current assets	157,619		207,286
Property, plant and equipment, net	33,185		32,129
Operating lease right-of-use assets	22,353		23,620
Goodwill	—		24,510
Other intangible assets, net	6,833		9,304
Deferred income tax assets, non-current	809		8,760
Income taxes receivable, non-current	5,673		5,673

Other assets	2,666		2,763
Total assets	$	229,138	$	314,045
Liabilities and Shareholders' Equity
Trade payables	$	26,764	$	53,165
Accrued liabilities	24,420		29,386
Operating lease liabilities, current portion	4,316		4,494
Financing lease liabilities, current portion	120		119
Warranty obligations, current portion	3,955		4,968
Income taxes payable, current portion	720		839
Debt payable, current portion, net of unamortized debt issuance costs of $57 and $57	2,243		2,243

Total current liabilities	62,538		95,214
Operating lease liabilities, non-current	19,778		20,926
Financing lease liabilities, non-current	367		395
Warranty obligations, non-current	1,041		1,248
Income taxes payable, non-current	4,054		4,029
Deferred income tax liabilities, non-current	500		—
Other non-current liabilities	1,270		1,071
Debt payable, non-current, net of unamortized debt issuance costs of $190 and $204	34,743		27,113
Total liabilities	124,291		149,996
Commitments and contingencies (Note 16)	0		0
Shareholders' equity:
Common stock - no par value, 75,000 shares authorized, 31,473 and 31,268 shares issued and outstanding	8,317		6,483
Retained earnings	97,916		158,093

Accumulated other comprehensive loss	(1,386)		(527)
Total shareholders' equity	104,847		164,049
Total liabilities and shareholders' equity	$	229,138	$	314,045

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except per share amounts)


		Three-Months Ended June 30,				Three-Months Ended June 30,
		2021		2020				2022		2021
Net sales	Net sales	$	184,593	$	114,188		Net sales	$	54,817	$	184,593
Cost of sales	Cost of sales	129,088		66,792			Cost of sales	47,860		129,088
Gross profit	Gross profit	55,505		47,396			Gross profit	6,957		55,505
Operating expenses:	Operating expenses:						Operating expenses:
Selling and marketing	Selling and marketing	21,300		12,446			Selling and marketing	12,891		21,300
General and administrative	General and administrative	11,523		9,315			General and administrative	12,463		11,523
Research and development	Research and development	4,815		3,728			Research and development	5,823		4,815
Loss on disposal group		0		29,013
Goodwill and intangible impairment charge							Goodwill and intangible impairment charge	26,965		—

Total operating expenses	Total operating expenses	37,638		54,502			Total operating expenses	58,142		37,638
Operating income (loss)		17,867		(7,106)
Operating (loss) income							Operating (loss) income	(51,185)		17,867
Other expense:	Other expense:						Other expense:
Interest income	Interest income	21		1			Interest income	1		21
Interest expense	Interest expense	(314)		(338)			Interest expense	(376)		(314)
Other, net	Other, net	(120)		115			Other, net	(514)		(120)
Total other expense, net	Total other expense, net	(413)		(222)			Total other expense, net	(889)		(413)
Income (loss) from continuing operations before income taxes		17,454		(7,328)
Income tax expense (benefit)		3,438		(2,342)
Income (loss) from continuing operations		14,016		(4,986)
(Loss) income from continuing operations before income taxes							(Loss) income from continuing operations before income taxes	(52,074)		17,454
Income tax expense							Income tax expense	8,096		3,438
(Loss) income from continuing operations							(Loss) income from continuing operations	(60,170)		14,016
Discontinued operations:	Discontinued operations:						Discontinued operations:
Loss from discontinued operations before income taxes	Loss from discontinued operations before income taxes	(126)		(29)			Loss from discontinued operations before income taxes	—		(126)
Income tax expense of discontinued operations	Income tax expense of discontinued operations	6		95			Income tax expense of discontinued operations	7		6
Loss from discontinued operations	Loss from discontinued operations	(132)		(124)			Loss from discontinued operations	(7)		(132)
Net income (loss)		$	13,884	$	(5,110)
Net (loss) income							Net (loss) income	$	(60,177)	$	13,884

Basic income (loss) per share from continuing operations		$	0.46	$	(0.17)
Basic (loss) income per share from continuing operations							Basic (loss) income per share from continuing operations	$	(1.92)	$	0.46
Basic loss per share from discontinued operations	Basic loss per share from discontinued operations	(0.01)		0			Basic loss per share from discontinued operations	—		(0.01)
Basic net income (loss) per share		$	0.45	$	(0.17)
Basic net (loss) income per share							Basic net (loss) income per share	$	(1.92)	$	0.45

Diluted income (loss) per share from continuing operations		$	0.43	$	(0.17)
Diluted (loss) income per share from continuing operations							Diluted (loss) income per share from continuing operations	$	(1.92)	$	0.43
Diluted loss per share from discontinued operations	Diluted loss per share from discontinued operations	0		0			Diluted loss per share from discontinued operations	—		—
Diluted net income (loss) per share		$	0.43	$	(0.17)
Diluted net (loss) income per share							Diluted net (loss) income per share	$	(1.92)	$	0.43

Shares used in per share calculations:	Shares used in per share calculations:						Shares used in per share calculations:
Basic	Basic	30,697		29,909			Basic	31,405		30,697
Diluted	Diluted	32,508		29,909			Diluted	31,405		32,508

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(Unaudited and in thousands)

Three-Months Ended June 30,
2021 2020
Net income (loss) $ 13,884 $ (5,110)
Other comprehensive income:
Unrealized gain on available-for-sale securities, net of income tax benefit of $7 and $0 0 0
Foreign currency translation, net of income tax benefit of $13 and $15 217 353
Other comprehensive income 217 353
Comprehensive income (loss) $ 14,101 $ (4,757)


	Three-Months Ended June 30,
	2022		2021
Net (loss) income	$	(60,177)	$	13,884
Other comprehensive (loss) income:


Foreign currency translation, net of income tax (expense) benefit of $(29) and $13	(859)		217
Other comprehensive (loss) income	(859)		217
Comprehensive (loss) income	$	(61,036)	$	14,101

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(Unaudited and in thousands)

Common Stock Retained Earnings Accumulated Other Comprehensive Income Total Shareholders' Equity
Shares Amount
Balances at March 31, 2021 30,576 $ 2,176 $ 180,524 $ (155) $ 182,545
Net income — — 13,884 — 13,884
Unrealized loss on marketable securities, net of income tax benefit of $7 — — — 0 0
Foreign currency translation adjustment,
  net of income tax benefit of $13
— — — 217 217
Stock-based compensation expense — 1,225 0 — 1,225
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 201 (1,259) — — (1,259)
Common stock issued under employee stock purchase plan 17 269 — — 269
Balances at June 30, 2021 30,794 $ 2,411 $ 194,408 $ 62 $ 196,881


	Common Stock			Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders' Equity
	Shares	Amount









Balance, March 31, 2022	31,268	$	6,483	$	158,093	$	(527)	$	164,049
Net loss	—	—		(60,177)		—		(60,177)


Foreign currency translation adjustment, net of income tax expense of $29	—	—		—		(859)		(859)
Stock-based compensation expense	—	1,979		—		—		1,979
Common stock issued under equity compensation plan, net of shares withheld for tax payments	205	(270)		—		—		(270)
Common stock issued under employee stock purchase plan	—	125		—		—		125

Balance, June 30, 2022	31,473	$	8,317	$	97,916	$	(1,386)	$	104,847

Common Stock Retained Earnings Accumulated Other Comprehensive Loss Total Shareholders' Equity
Shares Amount
Balances at March 31, 2020 29,817 $ 1,781 $ 92,456 $ (1,312) $ 92,925
Net loss — — (5,110) — (5,110)
Foreign currency translation adjustment,
  net of income tax benefit of $15
— — — 353 353
Stock-based compensation expense — 865 0 — 865
Common stock issued under equity
  compensation plan, net of shares withheld
  for tax payments 87 0 — — 0
Common stock issued under employee stock purchase plan 63 83 — — 83
Balances at June 30, 2020 29,967 $ 2,729 $ 87,346 $ (959) $ 89,116


	Common Stock			Retained Earnings		Accumulated Other Comprehensive (Loss) Income		Total Shareholders' Equity
	Shares	Amount









Balance, March 31, 2021	30,576	$	2,176	$	180,524	$	(155)	$	182,545
Net income	—	—		13,884		—		13,884


Foreign currency translation adjustment, net of income tax benefit of $13	—	—		—		217		217
Stock-based compensation expense	—	1,225		—		—		1,225
Common stock issued under equity compensation plan, net of shares withheld for tax payments	201	(1,259)		—		—		(1,259)
Common stock issued under employee stock purchase plan	17	269		—		—		269

Balance, June 30, 2021	30,794	$	2,411	$	194,408	$	62	$	196,881

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)


		Three-Months Ended June 30,					Three-Months Ended June 30,
		2021		2020			2022		2021
Cash flows from operating activities:	Cash flows from operating activities:					Cash flows from operating activities:
Income (loss) from continuing operations		$	14,016	$	(4,986)
(Loss) income from continuing operations						(Loss) income from continuing operations	$	(60,170)	$	14,016
Loss from discontinued operations	Loss from discontinued operations	(132)		(124)		Loss from discontinued operations	(7)		(132)
Net income (loss)		13,884		(5,110)
Adjustments to reconcile net income to cash provided by operating activities:
Net (loss) income						Net (loss) income	(60,177)		13,884
Adjustments to reconcile net (loss) income to cash used in operating activities:						Adjustments to reconcile net (loss) income to cash used in operating activities:
Depreciation and amortization	Depreciation and amortization	2,054		2,646		Depreciation and amortization	2,306		2,054
Provision for allowance for doubtful accounts		(156)		596
Recovery (provision) for allowance for doubtful accounts						Recovery (provision) for allowance for doubtful accounts	430		(156)
Inventory lower of cost or net realizable value	Inventory lower of cost or net realizable value	(134)		773		Inventory lower of cost or net realizable value	644		(134)
Stock-based compensation expense	Stock-based compensation expense	1,225		865		Stock-based compensation expense	1,979		1,225
Loss on asset dispositions		0		184
Deferred income taxes, net of valuation allowances						Deferred income taxes, net of valuation allowances	8,354		(908)
Goodwill and intangible impairment change						Goodwill and intangible impairment change	26,965		—
Other						Other	(666)		1,125

Loss on disposal group, goodwill and other intangible impairment charge		0		29,013
Deferred income taxes, net of valuation allowances		(908)		(7,523)

Other		1,125		(961)

Changes in operating assets and liabilities:	Changes in operating assets and liabilities:					Changes in operating assets and liabilities:
Trade receivables	Trade receivables	(9,638)		(7,995)		Trade receivables	33,966		(9,638)
Inventories	Inventories	(43,259)		1,506		Inventories	8,320		(43,259)
Prepaids and other assets	Prepaids and other assets	3,706		(611)		Prepaids and other assets	4,012		3,706
Income taxes receivable	Income taxes receivable	(9,512)		4,823		Income taxes receivable	282		(9,512)
Trade payables	Trade payables	15,200		19,742		Trade payables	(25,368)		15,200
Accrued liabilities and other liabilities, including warranty obligations	Accrued liabilities and other liabilities, including warranty obligations	(1,743)		2,264		Accrued liabilities and other liabilities, including warranty obligations	(7,027)		(1,743)

Net cash (used in) provided by operating activities		(28,156)		40,212
Net cash used in operating activities						Net cash used in operating activities	(5,980)		(28,156)
Cash flows from investing activities:	Cash flows from investing activities:					Cash flows from investing activities:

Proceeds from sales and maturities of available-for-sale securities	Proceeds from sales and maturities of available-for-sale securities	17,185		0		Proceeds from sales and maturities of available-for-sale securities	—		17,185

Purchases of property, plant and equipment						Purchases of property, plant and equipment	(3,381)		(1,850)

Purchases of property, plant and equipment		(1,850)		(2,965)

Net cash provided by (used in) investing activities	Net cash provided by (used in) investing activities	15,335		(2,965)		Net cash provided by (used in) investing activities	(3,381)		15,335
Cash flows from financing activities:	Cash flows from financing activities:					Cash flows from financing activities:
Proceeds from long-term debt	Proceeds from long-term debt	1,185		575		Proceeds from long-term debt	17,751		1,185
Payments on long-term debt	Payments on long-term debt	(1,337)		(13,167)		Payments on long-term debt	(10,446)		(1,337)

Payments on finance lease liabilities						Payments on finance lease liabilities	(30)		—
Proceeds from employee stock purchases	Proceeds from employee stock purchases	269		0		Proceeds from employee stock purchases	125		269
Proceeds from exercise of stock options	Proceeds from exercise of stock options	63		83		Proceeds from exercise of stock options	—		63
Tax payments related to stock award issuances	Tax payments related to stock award issuances	(1,322)		0		Tax payments related to stock award issuances	(270)		(1,322)

Net cash used in financing activities		(1,142)		(12,509)
Effect of exchange rate changes on cash and cash equivalents		740		644
(Decrease) increase in cash, cash equivalents and restricted cash		(13,223)		25,382
Less: Net change in cash balances classified as assets held-for-sale		0		(3,986)
Net change in cash, cash equivalents and restricted cash		(13,223)		21,396
Cash, cash equivalents and restricted cash:
Net cash provided by (used in) financing activities						Net cash provided by (used in) financing activities	7,130		(1,142)
Effect of exchange rate changes						Effect of exchange rate changes	(3,330)		740

Net decrease in cash, cash equivalents and restricted cash						Net decrease in cash, cash equivalents and restricted cash	(5,561)		(13,223)

Cash, cash equivalents and restricted cash at beginning of period	Cash, cash equivalents and restricted cash at beginning of period	39,780		26,456		Cash, cash equivalents and restricted cash at beginning of period	18,098		39,780
Cash, cash equivalents and restricted cash at end of period	Cash, cash equivalents and restricted cash at end of period	$	26,557	$	47,852	Cash, cash equivalents and restricted cash at end of period	$	12,537	$	26,557

Supplemental disclosure of cash flow information:	Supplemental disclosure of cash flow information:					Supplemental disclosure of cash flow information:
Cash paid for interest	Cash paid for interest	$	60	$	212	Cash paid for interest	$	176	$	60
Cash paid for income taxes, net		18,562		447
Cash (received from) paid for income taxes, net						Cash (received from) paid for income taxes, net	(514)		18,562
Supplemental disclosure of non-cash investing activities:	Supplemental disclosure of non-cash investing activities:					Supplemental disclosure of non-cash investing activities:
Capital expenditures incurred but not yet paid	Capital expenditures incurred but not yet paid	$	786	$	652	Capital expenditures incurred but not yet paid	$	1,335	$	786

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:	The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:					The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the Condensed Consolidated Balance Sheets to the total of the same amounts shown above:
		Three-Months Ended June 30,					Three-Months Ended June 30,
		2021		2020			2022		2021
Cash and cash equivalents	Cash and cash equivalents	$	25,218	$	45,656	Cash and cash equivalents	$	7,311	$	25,218
Restricted cash	Restricted cash	1,339		2,196		Restricted cash	1,339		1,339
Other current assets - restricted, current						Other current assets - restricted, current	3,887		—
Total cash, cash equivalents and restricted cash	Total cash, cash equivalents and restricted cash	$	26,557	$	47,852	Total cash, cash equivalents and restricted cash	$	12,537	$	26,557

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

NAUTILUS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

(1) GENERAL INFORMATION

Basis of Consolidation and Presentation

The accompanying condensed consolidated financial statements present the financial position, results of operations and cash flows of Nautilus, Inc. and its subsidiaries, all of which are wholly owned. Intercompany transactions and balances have been eliminated in consolidation.

On December 30, 2020, our Board of Directors approved a change in our fiscal year end from December 31st to March 31st. This document reflects our first quarter ending June 30, 2021 covering our fiscal year from April 1, 2021 through March 31, 2022.

The accompanying condensed consolidated financial statements have not been audited. We have condensed or omitted certain information and footnote disclosures normally included in financial statements presented in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Management believes the disclosures contained herein are adequate to make the information presented not misleading. However, these condensed consolidated financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended ~~December~~March 31, ~~2020~~2022 (the ~~“2020~~“2022 Form 10-K”).

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Uncertainties regarding such estimates and assumptions are inherent in the preparation of financial statements and actual results could differ from those estimates. These uncertainties will be heightened by the COVID-19 pandemic, as we may be unable to accurately predict the impact of COVID-19 going forward and as a result our estimates may change in the near term. Further information regarding significant estimates can be found in our ~~2020~~2022 Form 10-K. We have reclassified certain amounts in prior-period financial statements to conform to the current period's presentation. On the consolidated balance sheets, we have reclassified from accrued liabilities to income taxes payable, current portion.

In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments necessary to present fairly our financial position as of June 30, ~~2021~~2022 and March 31, ~~2021,~~2022, and our results of operations, comprehensive (loss) income and shareholders' equity for the three-month ~~periods~~period ended June 30, ~~2021~~2022 and ~~2020~~2021 and our cash flows for the three-month ~~periods~~period ended June 30, ~~2021~~2022 and ~~2020.~~2021. Interim results are not necessarily indicative of results for a full year. Our revenues typically vary seasonally, and this seasonality can have a significant effect on operating results, inventory levels and working capital needs.

Unless indicated otherwise, all information regarding our operating results pertain to our continuing operations.

Recent Accounting Pronouncements

Recently Adopted Pronouncements

~~ASU 2019-12~~

In December 2019, the FASB issued ASU 2019-12, “Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.” The amendments in ASU 2019-12 introduce the following new guidance: (1) provides a policy election to not allocate consolidated income taxes when a member of a consolidated tax return is not subject to income tax; and (2) provides guidance to evaluate whether a step-up in tax basis of goodwill relates to a business combination in which book goodwill was recognized or a separate transaction. The amendments in ASU 2019-12 make changes to the following current guidance: (1) making an intraperiod allocation if there is a loss in continuing operations and a gain outside of continuing operations; (2) determining when a deferred tax liability is recognized after an investor in a foreign entity transitions to or from the equity method of accounting; (3) accounting for tax law changes and year-to-date losses in interim periods; and (4) determining how to apply the income tax guidance to franchise taxes that are partially based on income. ASU 2019-12 is effective for public business entities' fiscal years,

~~Table of Contents~~

including interim periods within those fiscal years, beginning after December 15, 2020 with early adoption permitted. Our adoption of ASU 2019-12 as of January 1, 2021 had no material impact on our financial position, results of operations or cash flows.

~~Recently Issued Pronouncements Not Yet Adopted~~

~~ASU~~ ~~2020-04 and ASU 2021-01~~

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848),” which provides optional guidance related to reference rate reform and provides practical expedients for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. This guidance is applicable for our borrowing instruments, which use London Inter-bank Offered Rate (“LIBOR”) as a reference rate, which is effective beginning on March 12, 2020, and we may elect to apply the amendments prospectively through December 31, 2022. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. We do not expect the adoption of this guidance to have a material impact on our financial position, results of operations and cash flows.

ASU 2020-01

In January 2020, the ~~FASB~~Financial Accounting Standards Board ("FASB") issued ~~ASU~~Accounting Standards Update ("ASU") 2020-01, “Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815).” The amendments in ASU 2020-01 clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815, which could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. These amendments improve current GAAP by reducing diversity in practice and increasing comparability of the accounting for these interactions. ASU 2020-01 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. ~~We do~~The adoption of ASU 2020-01 in the first quarter of the fiscal year ending March 31, 2023 ('fiscal 2023') did not ~~expect~~have any effect on our financial position, results of operations or cash flows.

Table of Contents

ASU 2020-04 and ASU 2021-01

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848),” which provides optional guidance related to reference rate reform and provides practical expedients for contract modifications and certain hedging relationships associated with the transition from reference rates that are expected to be discontinued. This guidance is applicable for our borrowing instruments, which use London Inter-bank Offered Rate (“LIBOR”) as a reference rate, which is effective beginning on March 12, 2020, and we may elect to apply the amendments prospectively through December 31, 2022. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. The adoption of this guidance ~~would have a~~had no material impact on our financial position, results of operations ~~and~~or cash flows.

Recently Issued Pronouncements Not Yet Adopted

ASU 2016-13

In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires companies to measure credit losses utilizing a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. In May 2019, the FASB issued ASU 2019-05, which provides entities to have certain instruments with an option to irrevocably elect the fair value option. In November 2019, the FASB issued ASU 2019-11, which provides clarification and addresses specific issues about certain aspects of ASU 2016-13. In March 2020, the FASB issued ASC 2020-03, which provides an update to clarify or address specific issues. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those years. We do not expect the adoption of this guidance would have a material impact on our financial position, results of operations and cash flows.

(2) REVENUES

Our revenues from contracts with customers disaggregated by revenue source, excluding sales-based taxes, were as follows (in thousands):


		Three-Months Ended June 30,				Three-Months Ended June 30,
		2021		2020				2022		2021
Product sales	Product sales	$	179,811	$	110,595		Product sales	$	49,596	$	179,811
Extended warranties and services	Extended warranties and services	1,756		1,465			Extended warranties and services	1,042		1,756
Other(1)	Other(1)	3,026		2,128			Other(1)	4,179		3,026
Net sales	Net sales	$	184,593	$	114,188		Net sales	$	54,817	$	184,593

(1) Other revenue is primarily subscription revenue, freight and delivery and royalty ~~income~~income.

Subscriptions

Sales of our subscriptions are deemed to be one performance obligation and we recognize revenue from these arrangements ratably over the subscription ~~revenue.~~term as the performance obligation is satisfied. Revenue generated from subscriptions is recorded in our Direct segment.

We also offer free trials of subscriptions that are bundled with product offerings (e.g., subscription for premium content). For these types of transactions that involve multiple performance obligations, the transaction price requires allocations to the distinct performance obligation because the free trial provides a material right. The transaction price is then allocated to each performance obligation based on stand-alone selling price. We determine stand-alone selling price based on prices charged to customers. Breakage is factored into the determination of the stand-alone selling price of a subscription. Breakage or activation rate, is defined as a percentage of those purchases that never activate a free-trial offering.

Table of Contents

Our revenues disaggregated by geographic region, based on ship-to address, were as follows (in thousands):


		Three-Months Ended June 30,				Three-Months Ended June 30,
		2021		2020				2022		2021
United States	United States	$	147,149	$	97,363		United States	$	46,081	$	147,149
Canada	Canada	19,362		6,248			Canada	5,807		19,362
Europe, the Middle East and Africa	Europe, the Middle East and Africa	14,442		8,493			Europe, the Middle East and Africa	1,839		14,442
All other	All other	3,640		2,084			All other	1,090		3,640
Net sales	Net sales	$	184,593	$	114,188		Net sales	$	54,817	$	184,593

As of June 30, ~~2021,~~2022, estimated revenue expected to be recognized in the future totaled ~~$145.0~~$48.4 million, primarily related to customer order backlog, which includes firm orders for future shipment and unfulfilled orders to our Retail customers, as well as unfulfilled consumer orders within the Direct channel. ~~We have further refined our Retail backlog to include unfilled future orders. Direct orders of $3.1 million and Retail orders of $141.9 million, comprised our backlog as~~As of June 30, ~~2021, compared to~~2022, Retail orders were $48.0 million and Direct orders ~~of $20.6 million and Retail orders of $130.0 million as of June 30, 2020.~~were $0.4 million. The estimated future revenues are net of contractual rebates and consideration payable for applicable Retail customers, and net of current promotional programs and sales discounts for our Direct customers.

The following table provides information about our liabilities from contracts with customers, primarily customer deposits and deferred revenue for which advance consideration is received prior to the transfer of ~~control.~~control or the performance obligation is not satisfied. Revenue is recognized when transfer of control occurs. All customer deposits and deferred revenue received are short-term in nature, ~~and were recorded on~~recognized over the ~~condensed consolidated balance sheets as accrued liabilities.~~next twelve months. Significant changes in contract liabilities balances, including revenue recognized in the reporting period that was included in opening contract liabilities, are shown below (in thousands):

Three-Months Ended June 30,
2021 2020
Balance, beginning of period $ 5,551 $ 2,050
Cash additions 1,089 2,371
Revenue recognition (4,883) (918)
Balance, end of period $ 1,757 $ 3,503


	Three-Months Ended June 30,
	2022		2021
Balance, beginning of period	$	6,285	$	5,551
Cash additions	2,531		1,089
Revenue recognition	(2,234)		(4,883)
Balance, end of period	$	6,582	$	1,757

(3) FAIR VALUE MEASUREMENTS

Factors used in determining the fair value of financial assets and liabilities are summarized into three broad categories:

•Level 1 - observable inputs such as quoted prices (unadjusted) in active liquid markets for identical securities as of the reporting date;

•Level 2 - other significant directly or indirectly observable inputs, including quoted prices for similar securities, interest rates, prepayment speeds and credit ~~risk;~~risk, or observable market prices in markets with insufficient volume and/or infrequent transactions; and

•Level 3 - significant inputs that are generally unobservable inputs for which there is little or no market data available, including our own assumptions in determining fair value.

Table of Contents

Assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):

June 30, 2021
Level 1 Level 2 Level 3 Total
Assets:
Cash Equivalents
Money market funds $ 6,184 $ 0 $ 0 $ 6,184
Total cash equivalents 6,184 0 0 6,184
Available-for-Sale Securities
Commercial paper 0 7,998 0 7,998
Corporate bonds 0 8,153 0 8,153
U.S. government bonds 0 40,113 0 40,113
Total available-for-sale securities 0 56,264 0 56,264
Total assets measured at fair value $ 6,184 $ 56,264 $ 0 $ 62,448
Liabilities:
Derivatives
Foreign currency forward contracts $ 0 $ 510 $ 0 $ 510
Total liabilities measured at fair value $ 0 $ 510 $ 0 $ 510


	June 30, 2022
	Level 1		Level 2		Level 3		Total
Assets:













Derivatives

Foreign currency forward contracts	$	—	$	5	$	—	$	5

Total assets measured at fair value	$	—	$	5	$	—	$	5

Liabilities:
Derivatives

Foreign currency forward contracts	$	—	$	34	$	—	$	34
Total liabilities measured at fair value	$	—	$	34	$	—	$	34

March 31, 2021
Level 1 Level 2 Level 3 Total
Assets:
Cash Equivalents
Money market funds $ 9,679 $ 0 $ 0 $ 9,679
Total cash equivalents 9,679 0 0 9,679
Available-for-Sale Securities
Commercial paper 0 9,994 0 9,994
Corporate bonds 0 8,227 0 8,227
U.S. government bonds 0 55,227 0 55,227
Total available-for-sale securities 0 73,448 0 73,448
Total assets measured at fair value $ 9,679 $ 73,448 $ 0 $ 83,127
Liabilities:
Derivatives
Foreign currency forward contracts $ 0 $ 672 $ 0 $ 672
Total liabilities measured at fair value $ 0 $ 672 $ 0 $ 672


	March 31, 2022
	Level 1		Level 2		Level 3		Total
Liabilities:
Derivatives

Foreign currency forward contracts	$	—	$	128	$	—	$	128
Total liabilities measured at fair value	$	—	$	128	$	—	$	128

For our assets measured at fair value on a recurring basis, we recognize transfers between levels at the actual date of the event or change in circumstance that caused the transfer. There were no transfers between levels during the three-month period ended June 30, ~~2021,~~2022, nor for the ~~period~~fiscal year ended March 31, ~~2021.~~2022 ("fiscal 2022"). Additionally, we did not have any changes to our valuation techniques during either of these periods.

We classify our marketable securities as available-for-sale and, accordingly, record them at fair value. Level 1 investment valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 investment valuations are obtained from inputs, other than quoted market prices in active markets for identical assets, that are directly or indirectly observable in the marketplace and quoted prices in markets with limited volume or infrequent transactions. The factors or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. Unrealized holding gains and losses are excluded from earnings and are reported net of tax in comprehensive income until realized.

~~Table of Contents~~

The fair values of our foreign currency forward contracts are calculated as the present value of estimated future cash flows using discount factors derived from relevant Level 2 market inputs, including forward curves and volatility levels.

~~We did not have any changes to our valuation techniques during the three-month period ended June 30, 2021, nor for the year ended March 31, 2021.~~

We recognize or disclose the fair value of certain assets, such as non-financial assets, primarily property, plant and equipment, goodwill, other intangible assets and certain other long-lived assets in connection with impairment evaluations. All of our nonrecurring valuations use significant unobservable inputs and therefore fall under Level 3 of the fair value hierarchy.

~~As of June 30, 2021 and March 31, 2021, there were no assets or liabilities that were recorded at fair value on a nonrecurring basis.~~

The carrying values of cash and cash equivalents, restricted cash, trade receivables, prepaids and other current assets, trade payables and accrued liabilities approximate fair value due to their short maturities. The carrying value of our debt approximates its fair value and falls under Level 2 of the fair value hierarchy, as the interest rate is variable and based on current market rates.

During the quarter ended June 30, 2022, we evaluated the fair value of our goodwill and intangible assets because triggering events were identified. See Note 7 for additional information.

(4) DERIVATIVES

From time to time, we enter into interest rate swaps to fix a portion of our interest expense, and foreign exchange forward contracts to offset the earnings impacts of exchange rate fluctuations on certain monetary assets and liabilities. We do not enter into derivative instruments for any purpose other than to manage interest rate or foreign currency exposure. That is, we do not engage in interest rate or currency exchange rate speculation using derivative instruments.

We may hedge our net recognized foreign currency assets and liabilities with forward foreign exchange contracts to reduce the risk that our earnings and cash flows will be adversely affected by changes in foreign currency exchange rates. These derivative instruments hedge assets and liabilities that are denominated in foreign currencies and are carried at fair value with changes in the fair value recorded as other income. These derivative instruments do not subject us to material balance sheet risk due to exchange rate movements because gains and losses on these derivatives are intended to offset gains and losses on the assets and liabilities being hedged. As of June 30, ~~2021,~~2022, total outstanding contract notional amounts were ~~$66.0~~$14.7 million and had maturities of 7978 days or less.

Table of Contents

The fair value of our derivative instruments was included in our condensed consolidated balance sheets as follows (in thousands):

Balance Sheet Classification As of
June 30, 2021 March 31, 2021
Derivative instruments not designated as cash flow hedges:
Accrued liabilities $ 510 $ 672


	Balance Sheet Classification	As of
		June 30, 2022		March 31, 2022




Derivative instruments not designated as cash flow hedges:
Foreign currency forward contracts	Prepaids and other current assets	$	5	$	—
Foreign currency forward contracts	Accrued liabilities	34		128

The effect of derivative instruments on our condensed consolidated statements of operations was as follows (in thousands):


		Statement of Operations Classification		Three-Months Ended June 30,					Statement of Operations Classification			Three-Months Ended June 30,
			2021			2020					Statement of Operations Classification			2022				2021

Derivative instruments not designated as cash flow hedges:	Derivative instruments not designated as cash flow hedges:											Derivative instruments not designated as cash flow hedges:
Loss recognized in earnings	Loss recognized in earnings	Other, net		$	(17)		$	(141)		Loss recognized in earnings			Other, net			$	(96)			$	(17)
Income tax (benefit) expense		Income tax expense (benefit)		(4)			35
Income tax expense										Income tax expense		Income tax expense			(24)				(4)

~~Table of Contents~~

(5) INVENTORIES

Inventories are stated at the lower of cost and net realizable value, with cost determined based on the first-in, first-out method. Our inventories consisted of the following (in thousands):


		As of					As of
		June 30, 2021		March 31, 2021			June 30, 2022		March 31, 2022
Finished goods	Finished goods	$	106,413	$	63,918	Finished goods	$	98,521	$	104,988
Parts and components	Parts and components	4,719		4,167		Parts and components	5,411		6,202
Total inventories	Total inventories	$	111,132	$	68,085	Total inventories	$	103,932	$	111,190

(6) PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):


		Estimated Useful Life (in years)				As of							Estimated Useful Life (in years)								As of
					June 30, 2021			March 31, 2021				Estimated Useful Life (in years)									June 30, 2022			March 31, 2022
Automobiles	Automobiles		5					$	23					$	23						Automobiles		5			$	23			$	23
Leasehold improvements	Leasehold improvements	4	to	20		3,060				3,059						Leasehold improvements		4		to		20			3,646				3,150
Computer software and equipment	Computer software and equipment	2	to	7		38,244				36,956					Computer software and equipment		2		to		7			44,682				44,852
Machinery and equipment	Machinery and equipment	3	to	5		15,790				15,699					Machinery and equipment		3		to		5			16,017				16,447
Furniture and fixtures	Furniture and fixtures	5	to	20		2,587				2,586					Furniture and fixtures		5		to		20			2,632				2,634
Work in progress(1)	Work in progress(1)	N/A				2,196				1,314					Work in progress(1)		N/A							10,034				6,678
Total cost	Total cost					61,900				59,637					Total cost									77,034				73,784
Accumulated depreciation	Accumulated depreciation					(37,182)				(35,141)					Accumulated depreciation									(43,849)				(41,655)
Total property, plant and equipment, net	Total property, plant and equipment, net					$	24,718			$	24,496				Total property, plant and equipment, net									$	33,185			$	32,129

(1) Work in progress includes information technology assets and production tooling.

Table of Contents

Depreciation expense was as follows (in thousands):

Three-Months Ended June 30,
2021 2020
Depreciation expense $ 2,039 $ 1,843


	Three-Months Ended June 30,
	2022		2021
Depreciation expense	$	2,291	$	2,039

(7) GOODWILL AND OTHER INTANGIBLE ASSETS

Goodwill

The roll forward of goodwill was as follows (in thousands):


	Total
Balance, March 31, 2022	$	24,510
Goodwill impairment	(24,510)

Balance, June 30, 2022	$	—

In accordance with ASC 350 — Intangibles — Goodwill and Other, we perform our goodwill and indefinite-lived trade names impairment valuations annually, on March 31, or sooner if triggering events are identified. While the fair value of our reporting units exceeded their respective carrying values as of March 31, 2022, we observed continued market volatility including significant declines in our market capitalization during the three-month period ended June 30, 2022, identified as a triggering event. Our trailing 30-day average market capitalization was approximately $137 million at March 31, 2022 compared to $66 million, the trailing 30-day average as of June 30, 2022. We performed an interim evaluation and a market capitalization reconciliation during the first quarter of fiscal 2023, which resulted in non-cash goodwill impairment charge of $24.5 million.

We assigned assets and liabilities to each reporting unit based on either specific identification or by using judgment for the remaining assets and liabilities that are not specific to a reporting unit. We determined the fair value of our reporting units in Step 1 of the ASC 350 analysis using the market approach. In addition, we determined the fair value by adding a control premium observed from recent transactions of comparable companies to determine the reasonableness of that assumption and the fair values of the reporting units estimated in Step 1. Significant unobservable inputs and assumptions inherent in the valuation methodologies from Level 3 inputs were employed and include, but were not limited to, prospective financial information, growth rates, terminal value, royalty rates, discount rates, and comparable multiples from publicly traded companies in our industry. We compared the carrying amount of each reporting unit to its respective fair value. We reconciled the aggregate fair values of the reporting units determined in Step 1 (as described above) to the enterprise market capitalization plus a reasonable control premium. This total value was compared to a trailing 30-day average market capitalization of approximately $66 million as of June 30, 2022. As a result, the market capitalization reconciliation analysis identified that the Direct reporting unit's fair value was significantly lower than its carrying value, resulting in a non-cash goodwill impairment charge of $24.5 million.

Other Intangible Assets

Other intangible assets consisted of the following (in thousands):


		Estimated Useful Life (in years)				As of							Estimated Useful Life (in years)						As of
					June 30, 2021			March 31, 2021				Estimated Useful Life (in years)							June 30, 2022			March 31, 2022
Indefinite-lived trademarks(1)	Indefinite-lived trademarks(1)		N/A					$	9,052					$	9,052				Indefinite-lived trademarks(1)		N/A			$	6,597			$	9,052

Patents	Patents	7	to	24		1,443				1,443						Patents	7	to		24			1,043				1,043

						10,495				10,495												7,640				10,095
Accumulated amortization - definite-lived intangible assets	Accumulated amortization - definite-lived intangible assets					(1,145)				(1,130)					Accumulated amortization - definite-lived intangible assets							(807)				(791)
Other intangible assets, net	Other intangible assets, net					$	9,350			$	9,365				Other intangible assets, net							$	6,833			$	9,304

(1) During the first quarter of fiscal 2023, we identified impairment indicators with our indefinite-lived trademarks resulting in a $2.5 million non-cash intangible impairment charge.

Amortization expense was as follows (in thousands):

Three-Months Ended June 30,
2021 2020
Amortization expense $ 15 $ 803

Table of Contents


	Three-Months Ended June 30,
	2022		2021
Amortization expense	$	15	$	15

Future amortization of definite-lived intangible assets is as follows (in thousands):


2022		$	46
2023		61
Remainder of fiscal 2023				Remainder of fiscal 2023	$	46
2024	2024	61		2024	61
2025	2025	61		2025	61
2026	2026	47		2026	47
2027				2027	3
Thereafter	Thereafter	22		Thereafter	18
		$	298		$	236

(8) LEASES

We have several non-cancellable operating leases, primarily for office space, that expire at various dates over the next nine years. These leases generally contain renewal options to extend for 1 lease term of five years. For leases that we are reasonably certain we will exercise the lease renewal options, the options were considered in determining the lease term, and associated potential option payments are included in the lease payments. The payments used in the renewal term were estimated using the percentage rate increase of historical rent payments for each location where the renewal will be exercised.

Payments due under the lease contracts include annual fixed payments for office space. Variable payments including payments for our proportionate share of the building’s property taxes, insurance, and common area maintenance are treated as non-lease components and are recognized in the period for which the costs occur.

~~Operating lease~~

Lease expense was as follows (in thousands):

Three-Months Ended June 30,
2021 2020
Operating lease expense $ 1,466 $ 1,145


	Three-Months Ended June 30,
	2022		2021
Operating lease expense	$	1,533	$	1,466
Amortization of finance lease assets	28		—

Total lease expense	$	1,561	$	1,466

Leases with an initial term of 12 months or less (“short-term lease”) are not recorded on the balance sheet and are recognized on a straight-line basis over the lease term.

Other information related to leases was as follows ~~(dollars in~~(in thousands):

As of
June 30, 2021 March 31, 2021
Supplemental cash flow information:
Cash paid for amounts included in the measurement of operating lease liabilities:
Operating cash flow from operating leases $ 1,352 $ 1,076
Additional operating lease information:
Reductions to ROU assets resulting from reductions to operating lease obligations $ 359 $ 268
Weighted average remaining operating lease term (years) 6.26 6.97
Weighted average discount rate on operating leases 5.00% 4.95%

Table of Contents


	As of
	June 30, 2022		March 31, 2022
Supplemental cash flow information related to leases was as follows:

Operating leases:
Operating lease right-of-use-assets	$	22,353	$	23,620

Operating lease liabilities, non-current	$	19,778	$	20,926
Operating lease liabilities, current portion	4,316		4,494
Total operating lease liabilities	$	24,094	$	25,420

Finance leases:
Property, plant and equipment, at cost	$	512	$	569
Accumulated depreciation	(28)		(57)
Property, plant and equipment, net	$	484	$	512

Finance lease obligations, non-current	$	367	$	395
Finance lease obligations, current portion	120		119
Total finance lease liabilities	$	487	$	514

Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flow from operating leases	$	1,940	$	6,485
Finance cash flows from finance leases	30		60

Additional lease information:
ROU assets obtained in exchange for operating lease obligations	$	—	$	10,323
ROU assets obtained in exchange for finance lease obligations	—		569
Reductions to ROU assets resulting from reductions to operating lease obligations	316		1,358


Weighted Average Remaining Lease Term:
Operating leases	2.8 years		3.1 years
Finance leases	4.3 years		4.5 years

Weighted Average Discount Rate:
Operating leases	4.65%		4.65%
Finance leases	2.14%		2.14%

We determined the discount rate for leases using a portfolio approach to determine an incremental borrowing rate to calculate the right-of-use assets and lease liabilities.

~~Table of Contents~~

Maturities of ~~operating~~ lease liabilities under non-cancellable leases were as follows (in thousands):

As of
June 30, 2021
2022 $ 4,502
2023 5,606
2024 5,168
2025 5,330
2026 4,267
Thereafter 7,969
Total undiscounted lease payments 32,842
Less imputed interest (4,915)
Total lease liabilities $ 27,927

Table of Contents



	As of June 30, 2022
	Operating leases		Finance leases
Remainder of fiscal 2023	$	4,060	$	89
2024	5,528		120
2025	5,592		120
2026	4,509		120
2027	2,353		60
Thereafter	5,796		—
Total undiscounted lease payments	27,838		509
Less imputed interest	(3,744)		(22)
Total lease liabilities	$	24,094	$	487

(9) ACCRUED LIABILITIES

Accrued liabilities consisted of the following (in thousands):


								As of
		As of				June 30, 2022		March 31, 2022
		June 30, 2021		March 31, 2021
Payroll and related liabilities	Payroll and related liabilities	$	5,485	$	6,616		Payroll and related liabilities	$	9,233	$	10,405
Deferred revenue							Deferred revenue	6,581		6,285
Legal settlement (2)							Legal settlement (2)	4,602		4,250
Other							Other	2,786		4,013
Reserves (1)	Reserves (1)	3,405		2,624			Reserves (1)	1,218		4,433
Deferred revenue		1,757		5,551
Other		3,868		4,836

Total accrued liabilities	Total accrued liabilities	$	14,515	$	19,627		Total accrued liabilities	$	24,420	$	29,386

(1) Reserves is primarily consists of inventory, sales return, ~~inventory,~~ sales tax and product liability reserves.

(2) Legal settlement is a loss contingency accrual related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. For further information, see Note 16, Commitments and Contingencies.

(10) PRODUCT WARRANTIES

Our products carry defined warranties for defects in materials or workmanship which, according to their terms, generally obligate us to pay the costs of supplying and shipping replacement parts to customers and, in certain instances, pay for labor and other costs to service products. Outstanding product warranty periods range from thirty days to, in limited circumstances, the lifetime of certain product components. We record a liability at the time of sale for the estimated costs of fulfilling future warranty claims. If necessary, we adjust the liability for specific warranty-related matters when they become known and are reasonably estimable. Estimated warranty expense is included in cost of sales, based on historical warranty claim experience and available product quality data. Warranty expense is affected by the performance of new products, significant manufacturing or design defects not discovered until after the product is delivered to the customer, product failure rates, and higher or lower than expected repair costs. If warranty expense differs from previous estimates, or if circumstances change such that the assumptions inherent in previous estimates are no longer valid, the amount of product warranty obligations is adjusted accordingly.

Changes in our product warranty obligations were as follows (in thousands):


		Three-Months Ended June 30,					Three-Months Ended June 30,
		2021		2020			2022		2021
Balance, beginning of period	Balance, beginning of period	$	8,651	$	3,154	Balance, beginning of period	$	6,216	$	8,651
Accruals	Accruals	3,226		276		Accruals	844		3,226

Payments	Payments	(2,093)		(879)		Payments	(2,064)		(2,093)
Balance, end of period	Balance, end of period	$	9,784	$	2,551	Balance, end of period	$	4,996	$	9,784

(11) ACCUMULATED OTHER COMPREHENSIVE ~~INCOME (LOSS)~~LOSS

Table of Contents

The following tables set forth the changes in accumulated other comprehensive loss, net of tax (in thousands):


	Foreign Currency Translation Adjustments		Accumulated Other Comprehensive Loss
Balance, March 31, 2022	$	(527)	$	(527)
Current period other comprehensive loss before reclassifications	(859)		(859)

Net other comprehensive loss during period	(859)		(859)
Balance, June 30, 2022	$	(1,386)	$	(1,386)

~~Table of Contents~~


		Unrealized Loss on Available-for-Sale Securities		Gain (Loss) on Derivative Securities		Foreign Currency Translation Adjustments		Accumulated Other Comprehensive Income			Unrealized Loss on Available-for-Sale Securities		Foreign Currency Translation Adjustments		Accumulated Other Comprehensive (Loss) Income
Balance, March 31, 2021	Balance, March 31, 2021	$	(8)	$	0	$	(147)	$	(155)	Balance, March 31, 2021	$	(8)	$	(147)	$	(155)
Current period other comprehensive loss before reclassifications		0		0		217		217
Current period other comprehensive income before reclassifications										Current period other comprehensive income before reclassifications	—		217		217

Net other comprehensive loss during period		0		0		217		217
Net other comprehensive income during period										Net other comprehensive income during period	—		217		217
Balance, June 30, 2021	Balance, June 30, 2021	$	(8)	$	0	$	70	$	62	Balance, June 30, 2021	$	(8)	$	70	$	62

Unrealized (Loss) Gain on Available-for-Sale Securities Gain (Loss) on Derivative Securities Foreign Currency Translation Adjustments Accumulated Other Comprehensive Loss
Balance, March 31, 2020 $ 0 $ 0 $ (1,312) $ (1,312)
Current period other comprehensive loss before reclassifications 0 0 353 353
Net other comprehensive loss during period 0 0 353 353
Balance, June 30, 2020 $ 0 $ 0 $ (959) $ (959)

(12) (LOSS) INCOME ~~(LOSS)~~ PER SHARE

Basic per share amounts were computed using the weighted average number of common shares outstanding. Diluted per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method. Basic income per share amounts were computed using the weighted average number of common shares outstanding. Diluted income per share amounts were calculated using the number of basic weighted average shares outstanding increased by dilutive potential common shares related to stock-based awards, as determined by the treasury stock method.

The weighted average numbers of shares outstanding used to compute (loss) income per share were as follows (in thousands):


		Three-Months Ended June 30,		Three-Months Ended June 30,
		2021	2020			2022	2021
Shares used to calculate basic income per share	Shares used to calculate basic income per share	30,697	29,909		Shares used to calculate basic income per share	31,405	30,697
Dilutive effect of outstanding stock options, performance stock units and restricted stock units	Dilutive effect of outstanding stock options, performance stock units and restricted stock units	1,811	0		Dilutive effect of outstanding stock options, performance stock units and restricted stock units	—	1,811
Shares used to calculate diluted income per share	Shares used to calculate diluted income per share	32,508	29,909		Shares used to calculate diluted income per share	31,405	32,508

The weighted average numbers of shares outstanding listed in the table below were anti-dilutive and excluded from the computation of diluted income per share. In the case of restricted stock units, this is because unrecognized compensation expense exceeds the current value of the awards (i.e., grant date market value was higher than current average market price). In the case of stock options, this is because the average market price did not exceed the exercise price.

These shares may be anti-dilutive potential common shares in the future (in thousands):

Three-Months Ended June 30,
2021 2020
Restricted stock units 220 580
Stock options 0 45

1415

Table of Contents


	Three-Months Ended June 30,
	2022	2021

Stock options	2	—
RSUs	1,576	220
Total anti-dilutive shares excluded	1,578	220

(13) SEGMENT AND ENTERPRISE-WIDE INFORMATION

We have 2 operating segments, Direct and Retail. There were no changes in our operating segments during the three-months ended June 30, ~~2021.~~2022.

We evaluate performance of the operating segments using several factors, of which the primary financial measures are net sales and reportable segment contribution. Contribution is the measure of profit or loss, defined as net sales less product costs and directly attributable expenses. Directly attributable expenses include selling and marketing expenses, general and administrative expenses, and research and development expenses that are directly related to segment operations. Segment assets are those directly assigned to an operating segment's operations, primarily accounts receivable, inventories, goodwill and other intangible assets. Unallocated assets primarily include cash, cash equivalents and restricted cash, derivative securities, shared information technology infrastructure, distribution centers, corporate headquarters, prepaids and other current assets, deferred income tax assets and other assets. Capital expenditures directly attributable to the Direct and Retail segments were not significant in any period.

Table of Contents

Following is summary information by reportable segment (in thousands):

Three-Months Ended June 30,
2021 2020
Net sales:
Direct $ 63,396 $ 50,433
Retail 120,484 62,948
Royalty 713 807
Consolidated net sales $ 184,593 $ 114,188
Contribution:
Direct $ 6,759 $ 16,995
Retail 22,090 11,613
Royalty 713 807
Consolidated contribution $ 29,562 $ 29,415
Reconciliation of consolidated contribution to income (loss) from continuing operations:
Consolidated contribution $ 29,562 $ 29,415
Amounts not directly related to segments:
Operating expenses (11,695) (36,521)
Other expense, net (413) (222)
Income tax (expense) benefit (3,438) 2,342
Income (loss) from continuing operations $ 14,016 $ (4,986)

As of
June 30, March 31,
Assets: 2021 2021
Direct $ 45,176 $ 47,002
Retail 192,189 146,001
Unallocated corporate 145,021 161,227
Total assets $ 382,386 $ 354,230


	Three-Months Ended June 30,
	2022		2021
Net sales:
Direct	$	26,476	$	63,396
Retail	27,444		120,484
Royalty	897		713
Consolidated net sales	$	54,817	$	184,593

Contribution:
Direct	$	(9,893)	$	6,759
Retail	(5,408)		22,090
Royalty	897		713
Consolidated contribution	$	(14,404)	$	29,562

Reconciliation of consolidated contribution to (loss) income from continuing operations:
Consolidated contribution	$	(14,404)	$	29,562
Amounts not directly related to segments:
Operating expenses(1)	(36,781)		(11,695)
Other expense, net	(889)		(413)
Income tax expense	(8,096)		(3,438)
(Loss) income from continuing operations	$	(60,170)	$	14,016
(1) Included in unallocated Operating expenses is $25.4 million of Goodwill and intangible impairment charge related to the Direct segment and $1.6 million of intangible impairment charge related to the Retail segment that is not included in the contribution performance measured by the chief operating decision maker.


	As of
	June 30, 2022		March 31, 2022
Assets:
Direct	$	61,067	$	93,554
Retail	108,264		144,683
Unallocated corporate	59,807		75,808
Total assets	$	229,138	$	314,045

~~Table of Contents~~

The following customers accounted for 10% or more of total net sales as follows:


		Three-Months Ended June 30,				Three-Months Ended June 30,
		2021		2020				2022	2021
Amazon.com	Amazon.com	17.9	%	18.0	%		Amazon.com	29.4%	17.9%
Best Buy	Best Buy	17.1	%	*			Best Buy	*	17.1%

*Less than 10% of total net sales.	*Less than 10% of total net sales.						*Less than 10% of total net sales.

Table of Contents

(14) BORROWINGS

Wells Fargo Bank Credit Agreement

On ~~May 14,~~October 29, 2021, we amended ~~the~~our Credit Agreement dated January 31, 2020, ~~Credit Agreement~~ with Wells Fargo Bank, National Association ~~(“Wells Fargo”)~~ and lenders from time to time party thereto ~~(collectively with Wells Fargo~~ ("the ~~“Lenders”~~Lenders”) ~~(“Credit Agreement”), pursuant to which the~~. The Lenders ~~have~~ agreed, among other things, to make available to us an asset-based revolving loan facility, ~~in the aggregate principal amount of up to $55.0 million,~~ subject to a borrowing base (the “ABL Revolving Facility”), and a term loan facility ~~in the aggregate principal amount of $15.0 million~~ (the “Term Loan Facility” and together with the ABL Revolving Facility, the ~~“Wells Fargo Financing"~~“Credit Facility”). The aggregate principal amount available under the ABL Revolving Facility is $100.0 million (the “Revolver”), ~~in each case, as such amounts may increase or decrease in accordance with~~subject to a borrowing base. The unamortized balance on the ~~terms of the Credit Agreement.~~ S~~everal key features have been beneficially amended including permanently removing the $7.5 million minimum liquidity covenant and minimum EBITDA covenant that~~Term Loan was ~~scheduled to commence February 1, 2022.~~$11.5 million. The Credit Facility ~~now contains a single market-based 1.0x springing fixed charge coverage ratio tested only when availability is less than the greater of $6.0 million~~matures on October 29, 2026 and 12.5% of the Loan Cap, as defined in the Credit Agreement. Various borrowing base definitions and limits were also amended that will result in improved availability under the asset-based revolver. In addition to the above structural improvements, the interest rate on the term loan was reduced to LIBOR plus 4.50% versus 5.00%. The maturity date remains January 31, 2025 and the term loan continues to contain amortization as originally scheduled. The repayment of obligations under the Credit Agreement is secured by substantially all of our ~~assets. Principal~~assets, with principal and interest amounts ~~are~~ required to be paid as scheduled.

As of June 30, 2022, outstanding borrowings totaled $37.2 million, with $9.8 million and $27.4 million under our Term Loan Facility and Revolver, respectively. As of June 30, 2022, we were in compliance with the financial covenants of the Credit Agreement and $35.1 million was available for borrowing under the ABL Revolving Facility.

Interest on the ~~ABL Revolving Facility~~Revolver will accrue at ~~LIBOR~~the Secured Overnight Financing Rate ("SOFR") plus a margin of ~~1.75%~~1.86% to ~~2.25%~~2.36% (based on average quarterly availability) and interest on the Term Loan Facility will accrue at ~~LIBOR~~SOFR plus ~~4.50%~~4.61%. As of June 30, ~~2021,~~2022, our interest rate was ~~1.85%~~3.65% for the ~~ABL Revolving Facility~~Revolver and ~~4.60%~~6.40% for the Term Loan Facility.

As of June 30, 2021,outstanding borrowings, net of debt issuance costs, totaled $13.4 million, with $11.9 million and $1.5 million under our Term Loan Facility and ABL Revolving Facility, respectively. As of June 30, 2021, we were in compliance with the financial covenants of the Credit Agreement and $53.6 million was available for borrowing under the ABL Revolving Facility. Any outstanding balance is due and payable on January 31, 2025.

The balance sheet classification of the borrowings under the revolving loan credit facility has been determined in accordance with ASC 470, Debt. Borrowings outstanding under a revolving credit agreement that includes both a subjective acceleration clause and a requirement to maintain a springing lock-box arrangement are classified based on the provisions of ASC 470 because the lock-box remittances do not automatically reduce the debt outstanding.

(15) INCOME TAXES

Under ASC Topic 740, Accounting for Income Taxes, we must periodically evaluate deferred tax assets to determine if it is more-likely-than-not that the future tax benefits will be realized. If the negative evidence outweighs the positive, a valuation allowance must be recognized to reduce the net carrying amount of the deferred tax assets to the amount more-likely-than-not to be realized.

Evaluating the need for, and amount of, a valuation allowance for deferred tax assets often requires significant judgment and extensive analysis of all available evidence on a jurisdiction-by-jurisdiction basis. Such judgments require us to interpret existing tax law and other published guidance as applied to our circumstances. As part of this assessment, we consider both positive and negative evidence. The weight given to the potential effect of positive and negative evidence must be commensurate with the extent to which the strength of the evidence can be objectively verified. We generally consider the following, but are not limited to, objectively verified evidence to determine the likelihood of realization of the deferred tax assets:

•Our current financial position and our historical results of operations for recent years. We generally consider cumulative pre-tax losses in the three-year period ending with the current quarter or a projected three-year cumulative loss position within the next 12 months following the current quarter to be significant negative evidence.

•A pattern of objectively-measured historical and current financial reporting loss trend is heavily weighted as a source of negative evidence.

•Sources of taxable income of the appropriate character. Future realization of deferred tax assets is dependent on projected taxable income of the appropriate character. Future reversals of existing temporary differences are heavily weighted sources of objectively verifiable evidence. Projections of future taxable income exclusive of reversing temporary differences are a source of positive evidence only when the projections are combined with a history of recent profits and current financial trends and can be reasonably estimated.

•Carry-back and carry-forward periods available. The carry-back and carry-forward periods permitted under the tax law are objectively verified evidence.

•Tax planning strategies. Tax planning strategies can be, depending on their nature, heavily-weighted sources of objectively verifiable positive evidence when the strategies are available and can be reasonably executed. We consider tax planning strategies only if they are feasible and justifiable considering our current operations and our strategic plan. Tax planning strategies, if executed, may accelerate the recovery of a deferred tax asset so the tax benefit of the deferred tax asset can be carried back.

Management assesses the available positive and negative evidence to estimate whether sufficient future taxable income will be generated to permit use of the existing deferred tax assets. A significant new piece of objective negative evidence evaluated was the three-year cumulative losses projected to incur within the next twelve months.

Table of Contents

Such objective evidence limits the ability to consider other subjective evidence, such as our projections for future growth.

Based on this evaluation, as of June 30, 2022, Management determined that it was no longer more likely than not that the tax benefits from the existing U.S deferred tax assets would be realized. Accordingly, we recorded a $14.2 million valuation allowance in the first quarter of fiscal 2023 against our domestic uncovered net deferred tax assets.

(16) COMMITMENTS AND CONTINGENCIES

Operating leases

We lease property and equipment under non-cancellable operating leases which, in the aggregate, extend through 2029. Many of these leases contain renewal options and provide for rent escalations and payment of real estate taxes, maintenance, insurance and certain other operating expenses of the properties.

For additional information related to leases, see Note 8, Leases.

Guarantees, Commitments and Off-Balance Sheet Arrangements

As of June 30, ~~2021,~~2022, we had standby letters of credit of $0.9 million.

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of June 30, ~~2021,~~2022, we had approximately ~~$174.9~~$34.5 million compared to ~~$216.3~~$39.8 million as of March 31, ~~2021~~2022 in ~~non-cancelable~~non-cancellable market-based purchase obligations, primarily to ~~secured~~secure additional factory capacity for inventory purchases in the next twelve months. The decrease in purchase obligations was primarily due to having received much of the inventory we have ordered for the season. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses.

~~Table of Contents~~

under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnification obligations vary from contract to contract, and generally a maximum obligation is not stated within the agreements. We hold insurance policies that mitigate potential losses arising from certain types of indemnification obligations. Management does not deem these obligations to be significant to our financial position, results of operations or cash flows, and therefore, no related liabilities were recorded as of June 30, ~~2021.~~2022.

Legal Matters

From time to time, in the ordinary course of business, we may be involved in various claims, lawsuits and other proceedings. These legal and tax proceedings involve uncertainty as to the eventual outcomes and losses which may be realized when one or more future events occur or fail to occur.

We regularly monitor our estimated exposure to these contingencies and, as additional information becomes known, may change our estimates accordingly. We evaluate, on a quarterly basis, developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would make a loss probable or reasonably possible, and whether the amount of a probable or reasonably possible loss is estimable. Among other factors, we evaluate the advice of internal and external counsel, the outcomes from similar litigation, the current status of the lawsuits (including settlement initiatives), legislative developments and other factors. Due to the numerous variables associated with these judgments and assumptions, both the precision and reliability of the resulting estimates of the related loss contingencies are subject to substantial uncertainties. Further, while we face contingencies that are reasonably possible to occur, other than as discussed below, we are unable to estimate the possible loss or range of loss at this time. ~~As such, 0 liability is recorded as of June 30, 2021.~~

~~As of the date of filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.~~

1719

Table of Contents

During the second quarter of fiscal 2022, we recorded a $4.7 million loss contingency related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. The settlement included damages, a one-year free membership to JRNY®, and administrative fees and was included as a component of General and administrative on our Condensed Consolidated Statements of Operations. As of June 30, 2022, $4.6 million remained accrued and was reflected in Accrued liabilities on our Condensed Consolidated Balance Sheets. We expect to pay the settlement damages and related administrative fees during the second fiscal quarter of fiscal 2023.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis is based upon our financial statements as of the dates and for the periods presented in this section. You should read this discussion and analysis in conjunction with the financial statements and notes thereto found in Part I, Item 1 of this Form 10-Q and our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the fiscal year ended ~~December~~March 31, ~~2020~~2022 (the ~~“2020~~“2022 Form 10-K”). All references to the first ~~quarter~~quarters of ~~2021~~fiscal 2023 and ~~2020~~fiscal 2022 mean for the three-month ~~periods~~period ended June 30, ~~2021~~2022 and ~~2020,~~2021, respectively. Unless the context otherwise requires, “Nautilus,” “we,” “us” and “our” refer to Nautilus, Inc. and its subsidiaries. Unless indicated otherwise, all information regarding our operating results pertains to our continuing operations.

Cautionary Notice About Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plan,” “expect,” “aim,” “believe,” “project,” “intend,” “estimate,” “will,” “should,” “could,” and other terms of similar meaning typically identify forward-looking statements. We also may make forward-looking statements in our other documents filed with or furnished to the U.S. Securities and Exchange Commission (the “SEC”). In addition, our senior management may make forward-looking statements orally to analysts, investors, representatives of the media and others. Forward-looking statements include any statements related to our future business, financial performance or operating results; anticipated fluctuations in net sales due to seasonality; plans and expectations regarding gross and operating margins; plans and expectations regarding research and development expenses and capital expenditures and anticipated results from such expenditures and other investments in our capabilities and resources; anticipated losses from discontinued operations; plans for new product introductions, strategic partnerships and anticipated demand for our new and existing products; and statements regarding our inventory and working capital requirements and the sufficiency of our financial resources. These forward-looking statements, and others we make from time-to-time, are subject to a number of risks and uncertainties. Many factors could cause actual results to differ materially from those projected in forward-looking statements, including our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs, changes in consumer fitness trends, changes in the media consumption habits of our target consumers or the effectiveness, availability and price of media time consistent with our cost and audience profile parameters, greater than anticipated costs or delays associated with launch of new products, weaker than expected demand for new or existing products, a decline in consumer spending due to unfavorable economic conditions, softness in the retail marketplace or the availability from retailers of heavily discounted competitive products, an adverse change in the availability of credit for our customers who finance their purchases, our ability to pass along vendor raw material price increases and other cost pressures, including increased shipping costs and unfavorable foreign currency exchange rates, tariffs, risks associated with current and potential delays, work stoppages, or supply chain disruptions caused by the coronavirus pandemic, our ability to hire and retain key management personnel, our ability to effectively develop, market and sell future products, the availability and timing of capital for financing our strategic initiatives, including being able to raise capital on favorable terms or at all; changes in the financial markets, including changes in credit markets and interest rates that affect our ability to access those markets on favorable terms, the impact of any future impairments, our ability to protect our intellectual property, the introduction of competing products, and our ability to get foreign-sourced product through customs in a timely manner. Additional assumptions, risks and uncertainties are described in Part I, Item 1A, “Risk Factors,” in our ~~2020~~2022 Form 10-K as supplemented or modified in our quarterly reports on Form 10-Q. We do not undertake any duty to update forward-looking statements after the date they are made or conform them to actual results or to changes in circumstances or expectations.

Overview

We empower healthier living through individualized connected fitness ~~experiences. We~~experiences and are committed to ~~build~~building a healthier world, one person at a time. Our principal business activities include designing, developing, sourcing and marketing high-quality cardio and strength fitness products, related accessories and digital platform for consumer use, primarily in the U.S., Canada, Europe and Asia. Our products are sold under some of the most-recognized brand names in the fitness industry: Bowflex®, Schwinn®, JRNY® and Nautilus®.

We market our products through two distinct distribution channels, Direct and Retail, which we consider to be separate business segments. Our Direct business offers products directly to consumers primarily through websites. Our Retail business offers our products through a network of independent retail companies to reach consumers in the home use markets in the U.S. and internationally. We also derive a portion of our revenue from the licensing of our brands and intellectual property.

1821

Table of Contents

As previously disclosed, we changed our fiscal year from the twelve months beginning January 1 and ending December 31 to the twelve months beginning April 1 and ending March 31 in order to include the primary fitness seasonOur results for ~~exercise equipment, October to March, in the same fiscal year. In addition, the new fiscal year-end is better aligned with the fiscal year-end of our retail partners.~~

~~For~~ the three-months ended June 30, ~~2021, our results were primarily impacted~~2022, are driven by ~~strong demand driven by~~the actions outlined in our North Star ~~strategy and the at home fitness surge.~~strategy. The five strategic pillars of our North Star ~~are~~strategy are: (1) Adopt a consumer first mindset; (2) Scale a differentiated digital offering; (3) Focus investments on core businesses; (4) Evolve supply chain to be a strategic advantage; and (5) Build organizational capabilities to win by unleashing the power of our team. We ~~will~~intend to leverage our many strengths to transform into a company that empowers healthier living through individualized connected fitness experiences. Our transformation will properly leverage our leading brands, products, innovation, distribution and digital assets to build a healthier world, one person at a time.

At the center of health and well-being is fitness and the market has so far behaved largely as we expected. The market size more than doubled over the past 2 years, is regulating from its peak with more normal seasonality, and we expect will settle at a “new normal” significantly above pre-pandemic levels based on a profound evolution in consumers’ workouts and workplace habits. As a result of these changed habits and sentiments, we continue to believe much of the industry growth opportunity will remain at elevated levels relative to pre-pandemic. This results in stronger opportunity for our industry and Nautilus.

For fiscal 2023, we expect to return to a more typical pre-pandemic seasonality, with the second half of the fiscal year contributing more of the full year's revenue. Additionally, to gauge sales growth and progress against more "normalized," or pre-pandemic results, we will rely more heavily on measuring performance of fiscal 2023 sales growth versus the pre-pandemic twelve-month period ended March 31, 2020 ("fiscal 2020") to guide business strategy, rather than measuring performance against the atypical, outsized results that occurred during the pandemic.

Comparison for the Three-Months Ended June 30, 2022 to the Three-Months ended June 30, 2021

•Net sales ~~for the three-months ended June 30, 2021~~ were $54.8 million, compared to $184.6 million, ~~reflecting~~ a ~~61.7% increase as~~decline of 70.3% versus last year. Net sales are up 11%, or 3% CAGR, when compared to ~~net sales of $114.2 million for~~ the ~~three-months ended June 30, 2020. Sales were up 74.4%,~~same period in fiscal 2020, excluding sales related to the Octane brand, which was sold in October ~~2020.Sales growth was~~2020. The sales decline versus last year is driven primarily by ~~continued demand for connected fitness bikes and treadmills, like~~ the ~~Bowflex~~® ~~VeloCore~~® ~~bike and Bowflex~~® ~~T22 Treadmill, and robust sales of SelectTech~~® ~~weights.~~return to pre-pandemic seasonal demand.

•Net sales of our Direct segment ~~increased~~decreased by ~~$13.0~~$36.9 million, or ~~25.7%~~58.2%, for the three-months ended June 30, ~~2021,~~2022, compared to the three-months ended June 30, ~~2020.~~2021. The net sales decrease was primarily driven by higher sales discounting and the return to pre-pandemic seasonal demand.

•Net sales of our Retail segment ~~increased~~decreased by ~~$57.5~~$93.0 million, or ~~91.4%~~77.2%, for the three-months ended June 30, ~~2021,~~2022, compared to the three-months ended June 30, ~~2020.~~2021. Excluding sales related to the Octane brand, which was sold in 2020, net sales ~~grew 120.7%.~~were down 2%, or a -1% CAGR, compared to the same period in fiscal 2020. The decrease in sales compared to last year is primarily driven by lower cardio sales and higher sales discounting as Retailers work through higher-than-normal inventory levels.

•Royalty income for the three-months ended June 30, ~~2021 decreased~~2022 increased by ~~$0.1~~$0.2 million compared to the three-months ended June 30, ~~2020.~~2021.

•Gross profit ~~for the three-months ended June 30, 2021~~ was $7.0 million, compared to $55.5 million ~~reflecting a 17.1% increase as~~last year. Gross profit margins were 12.7% compared to ~~gross profit of $47.4 million for the three-months ended June 30, 2020.Gross margin rate for the three-months ended June 30, 2021 was~~ 30.1% ~~compared to 41.5% for the three-months ended June 30, 2020. This margin pressure is the result of current macro events affecting not just the Company but many others as well.~~last year. The ~~11.4~~17.4 ppt decrease in gross margins was primarily due ~~to: higher landed product costs driven by inflationary price increases~~to increased discounting (-8 ppts), unfavorable logistics overhead absorption (-8 ppts) and increased investments in ~~commodities and components, foreign exchange, and elevated transportation costs, partially~~JRNY® (-4 ppts), offset by ~~sales price increases (-6~~improvements in other costs (3 ppts)~~, channel mix as Direct segment sales were 34% versus 44% last year (-3 ppts), outbound freight (-1 ppt), and a strategic decision to end production of select SKUs (-1 ppt)~~.

•Operating expenses ~~for the three-months ended June 30, 2021~~ were ~~$37.6~~$58.1 million, ~~a decrease~~an increase of ~~$16.9~~$20.5 million, or ~~30.9%~~54.5%, as compared to ~~operating expenses of $54.5 million for the three-months ended June 30, 2020,~~last year, primarily due to ~~the $29.0~~a goodwill and intangible impairment charge of $27.0 million ~~loss on disposal group for the same period last year~~and a $3.6 million increase in JRNY® investments, partially offset by ~~increased~~$5.7 million lower media spending and $2.7 million lower other variable selling and marketing expenses ~~as the Direct business returned~~due to ~~more normalized levels of advertising and the company invested in incremental brand marketing.~~decreased sales. Total advertising expenses were ~~$11.6~~$5.1 million ~~this year~~ versus ~~$2.8~~$10.8 million last year. ~~General and administrative expenses and product development expenses also increased versus~~

Table of Contents

•Operating loss was $51.2 million or negative 93.4% operating margin, compared to operating income of $17.9 million last year, primarily driven by ~~investments in JRNY~~®.a goodwill and intangible impairment charge of $27.0 million and lower gross profit associated with lower sales demand during the period.

•~~Operating income for the three-months ended June 30, 2021~~Loss from continuing operations was ~~$17.9~~$60.2 million, or ~~9.7% operating margin, a $25.0 million improvement~~$(1.92) per diluted share, compared to ~~an operating loss~~income of ~~$7.1~~$14.0 million, ~~for the three-months ended June 30, 2020. JRNY~~® ~~investments were $4.6 million this year versus $1 million~~or $0.43 per diluted share, last ~~year and brand marketing was $3.4 million this year versus $0 last~~ year. ~~Excluding these investments, our Q1 2022 operating margins have been improved by 4 percentage points.~~

•~~Income from continuing operations~~Net loss was ~~$14.0~~$60.2 million, ~~for the three-months ended June 30, 2021,~~or $(1.92) per diluted share, compared to net income of $13.9 million or $0.43 per diluted share, ~~compared to a loss from continuing operations of $5.0 million, or $0.17 per diluted share, for the three-months ended~~ ~~June 30, 2020.~~

~~Table of Contents~~

•~~Net income was~~ ~~$13.9 million~~ ~~for the three-months ended~~ ~~June 30, 2021, compared to net loss of~~ ~~$5.1 million~~ ~~for the three-months ended June 30, 2020.~~last year.

•The ~~effective~~income tax ~~rates~~ ~~for~~expense was $8.1 million this year compared to $3.4 million last year. The income tax expense this year was primarily a result of a U.S. deferred tax asset valuation allowance in the ~~three-months ended June 30, 2021 and for the three-months ended~~ amount of $14.2 million recorded this quarter.

~~June 30, 2020 were 19.7% and 32.0%, respectively.~~

North Star Strategy Update

JRNY® ~~update~~Digital Platform

•Nautilus ~~Inc. continues~~is continuing to enhance the JRNY® platform ~~creating~~through many unique features including the expansion of differentiated ~~connected fitness~~visual connected-fitness experiences for ~~their members. In the past quarter, the Company enhanced its content library, adding 200+ trainer-led videos and commissioning additional Explore the World content. They introduced the~~ JRNY® ~~app for use with its popular IC4 and C6 bikes further expanding its diverse lineup of connected products.~~Members.

~~Today, Nautilus also announced a strategic partnership with digital fitness provider, FitOn. Under the agreement, JRNY~~•® ~~members will have access to hundreds~~As of ~~off-product workouts through the JRNY~~® ~~digital~~June 30, 2022, Members of JRNY®, Nautilus’ personalized connected fitness platform, exceeded 360k representing approximately 133% growth versus the same quarter last year. Of these members, 127k were Subscribers, representing approximately 290% growth over the same period. We define JRNY® Members as all individuals who have a JRNY® account and/or subscription, which includes Subscribers, their respective associated users and ~~app~~users who consume free content. We define Subscribers as a person or household who paid for a Subscription, are in a trial, or have requested a "pause"' to ~~keep members engaged~~their subscriptions for up to three months.

•Additionally, the Company has made great strides over the last two years expanding the number of products featuring JRNY® connectivity. In FY 2022, approximately 80% of total units sold were JRNY® compatible, compared to only 22% in the pre-pandemic FY 2020. The trend of approximately 80% of total units sold being JRNY® compatible continued in Q1 FY 2023.

•Nautilus' integration of VAY's motion-tracking capabilities into JRNY® will further advance and ~~reaching their fitness goals.~~accelerate personalized strength workout options, including the addition of rep counting and form coaching for SelectTech® users, which we believe will drive JRNY® membership growth during FY 2023.

Forward Looking Guidance

~~Second Quarter Fiscal~~The following forward-looking statements reflect the Company's full fiscal year 2023 expectations as of August 9, 2022, and are subject to risks and uncertainties.

•The Company’s revenue for the next few quarters will be compared to record results due to the pandemic’s effect on net sales last year. To gauge continued progress against the expanded addressable market, the Company ~~will be measuring business versus last year~~is reiterating Second Half and ~~versus the same period two years ago for the next few quarters.~~Full Year 2023 Guidance.

•~~Demand curves for the Direct segment in Q1~~Second Half and in the first month of Q2 have started to revert to more typical seasonality patterns. Now that Direct’s backlog has returned to more normal levels, the Company expects Direct sales in Q2 to be lower than Q1.Fiscal 2023

•The Company expects ~~total company net sales for the 2nd quarter~~full year revenue of ~~fiscal 2022 to be~~ between ~~$145~~$380 million and ~~$155 million, a 2-year revenue CAGR of 53% to 59%.~~

•~~Similar to many other companies, the Company expects external gross margin challenges to continue in Q2 and anticipates increased price pressure due to the ongoing chip shortage.~~

•The Company was pleased with the results of North Star investment in Q1 and plans to continue investing in Q2. Brand marketing expenditures will be between $5 million and $6 million versus $3 million last quarter and zero last year. JRNY® ~~investment will be between $5.5 million and $6.5 million versus $5 million last quarter and $1 million last year. JRNY~~® investments will further enhance platform functionality via improved adaptive workouts, the addition of a member portal, and additional fresh content, like the ones provided by their new partner FitOn. The Company expects these investments to dilute operating margins by 7 to 8 percentage points.$460 million.

•Given ~~these investments and~~ the ~~external macro pressure on gross margin,~~impact of elevated inventory levels at the Company’s retail partners, the Company expects ~~operating margins~~the 2nd half of the year to ~~be in the low single digits.~~

~~Back Half~~represent between 65% and 70% of ~~Fiscal 2022~~

•~~The Company expects to continue investing in North Star on a “pay as we go” basis.~~full year sales, slightly higher than pre-pandemic 2nd half seasonality of approximately 60%.

•Gross margins for the second half of the year are expected to be in the range of 27% to 30%. Improvements versus last year are driven by lower in-bound freight and demurrage fees, and the reduction in logistics facilities footprint. The Company ~~assumes that the external macro factors negatively affecting gross margins will continue in Q3 and Q4. Although it’s unclear~~is closing one of its distribution centers when the ~~pressure~~associated lease expires in the Fall of 2022 and will ~~ease,~~not be renewing the ~~Company expects that over time, prices will stabilize and eventually return closer to pre-pandemic levels.~~leases of some storage locations.

•~~Until the macro environment improves, the Company expects operating margins to be in the low to mid-single digits for the back half of the year.~~

•~~The Company continues to~~We expect ~~full year capital expenditures to be between $12 million and $14 million with the majority earmarked for~~ JRNY® ~~investments.~~

members to exceed 500,000 at March 31, 2023.

2023

Table of Contents

•~~The Company reiterates their expectation of reaching 250,000 JRNY~~® ~~members by the end of FY22~~

~~Longer term view, beyond Fiscal 2022~~

•~~The Company’s conviction in their North Star strategy has never been stronger. Growth in JRNY~~® ~~members and their increased engagement confirm the Company’s expectations that their North Star investments will ultimately yield higher quality recurring revenue and long-term profitable growth.~~

•The Company believes the near-term external gross margin pressures are temporary and are not delaying the Company’s expectations of achieving sustainable operating margins upwards of 15% by FYE 2026, as they realize the long-term benefits of their transformational investments.

Factors Affecting Our Performance

Our results of operations may vary significantly from period-to-period.

Our revenues typically fluctuate due to the seasonality of our industry, customer buying patterns, product innovation, the nature and level of competition for health and fitness products, our ability to procure products to meet customer demand, the level of spending on, and effectiveness of, our media and advertising programs and our ability to attract new customers and maintain existing sales relationships. In addition, our revenues are highly susceptible to economic factors, including, among other things, the overall condition of the economy and the availability of consumer credit in both the U.S. and Canada. The COVID-19 pandemic ~~has~~ created a heightened need for home-fitness products at an ~~unplanned rate. We are unable~~unprecedented rate and as the pandemic lessened there was a return to ~~estimate the length of time that the short-term increases in demand for many of our home-fitness products will outpace supply and we are accelerating the manufacturing and delivery of key products.~~a more normal seasonality. We cannot predict with certainty the longer-term impacts of the COVID-19 pandemic and the change to consumer habits and sentiments and therefore, the impact on our results of operations is uncertain.

Our gross margins are being impacted by, ~~fluctuations~~among other things:

•Increased product costs, primarily driven by our increasing use of more expensive components in our products, which now include our connected fitness JRNY® platform.

•Fluctuations in the availability, and as a result the costs, ~~or availability~~ of materials used to manufacture our ~~products, tariffs,~~products.

•Tariffs and expedited shipping and transportation ~~costs and product warranty~~ costs. ~~Gross margins may also be affected by fluctuations~~

•Fluctuations in cost associated with the acquisition or license of products and technologies, product warranty ~~costs, the cost of~~claims, fuel, foreign currency exchange rates, and changes in costs of other distribution or manufacturing-related services.

•Costs relating to the addition of a new distribution facility in Southern California prior to the anticipated exit from our Portland DC facility.

•The efficiency and effectiveness of our organization and operations.

•A return to product discounting practices in place prior to the pandemic, which were temporarily suspended in part during the pandemic.

Our operating profits or losses may also be affected by the efficiency and effectiveness of our organization. Historically, our operating expenses have been influenced by media costs to produce and distribute advertisements of our products on television, websites and other media, facility costs, operating costs of our information and communications systems, product supply chain management, customer support and new product development activities. In addition, our operating expenses have been affected from time-to-time by asset impairment charges, restructuring charges and other significant unusual or infrequent expenses.

As a result of the above and other factors, our period-to-period operating results may not be indicative of future performance. You should not place undue reliance on our operating results and should consider our prospects in light of the risks, expenses and difficulties typically encountered by us and other companies, both within and outside our industry. We may not be able to successfully address these risks and difficulties and, consequently, we cannot assure you of any future growth or profitability. For more information, see our discussion of risk factors located at Part I, Item 1A of our ~~2020~~2022 Form 10-K as supplemented by our quarterly reports on Form 10-Q.

Discontinued Operations

Results from discontinued operations relate to the disposal of our former Commercial business, which was completed in April 2011. We reached substantial completion of asset liquidation as of December 31, 2012. Although there was no revenue related to the former Commercial business in ~~either~~ the ~~2021~~fiscal 2022 or ~~2020~~year-to-date fiscal 2023 periods, we continue to incur product liability and other legal expenses associated with product previously sold into the Commercial channel.

2124

Table of Contents

RESULTS OF OPERATIONS

Results of operations information was as follows ~~(dollars in~~(in thousands):

Three-Months Ended June 30, Change
2021 2020 $ %
Net sales $ 184,593 $ 114,188 $ 70,405 61.7 %
Cost of sales 129,088 66,792 62,296 93.3 %
Gross profit 55,505 47,396 8,109 17.1 %
Operating expenses:
Selling and marketing 21,300 12,446 8,854 71.1 %
General and administrative 11,523 9,315 2,208 23.7 %
Research and development 4,815 3,728 1,087 29.2 %
Loss on disposal group — 29,013 (29,013) (100.0) %
Total operating expenses 37,638 54,502 (16,864) (30.9) %
Operating income (loss) 17,867 (7,106) 24,973 (351.4) %
Other expense:
Interest income 21 1 20 2,000.0 %
Interest expense (314) (338) 24 (7.1) %
Other, net (120) 115 (235) *
Total other expense, net (413) (222) (191) 86.0 %
Income (loss) from continuing operations before income taxes 17,454 (7,328) 24,782
Income tax expense (benefit) 3,438 (2,342) 5,780
Income (loss) from continuing operations 14,016 (4,986) 19,002
Loss from discontinued operations, net of income taxes (132) (124) (8)
Net income (loss) $ 13,884 $ (5,110) $ 18,994

*Not meaningful


	Three-Months Ended June 30,				Change
	2022		2021		$		%
Net sales	$	54,817	$	184,593	$	(129,776)	(70.3)	%
Cost of sales	47,860		129,088		(81,228)		(62.9)	%
Gross profit	6,957		55,505		(48,548)		(87.5)	%
Operating expenses:
Selling and marketing	12,891		21,300		(8,409)		(39.5)	%
General and administrative	12,463		11,523		940		8.2	%
Research and development	5,823		4,815		1,008		20.9	%

Goodwill and intangible impairment charge	26,965		—		26,965		NM
Total operating expenses	58,142		37,638		20,504		54.5	%
Operating (loss) income	(51,185)		17,867		(69,052)		(386.5)	%
Other expense:
Interest income	1		21		(20)
Interest expense	(376)		(314)		(62)
Other, net	(514)		(120)		(394)
Total other expense, net	(889)		(413)		(476)
(Loss) income from continuing operations before income taxes	(52,074)		17,454		(69,528)
Income tax expense	8,096		3,438		4,658
(Loss) income from continuing operations	(60,170)		14,016		(74,186)
Loss from discontinued operations, net of taxes	(7)		(132)		125
Net (loss) income	$	(60,177)	$	13,884	$	(74,061)
NM = Not meaningful

2225

Table of Contents

Results of operations information by segment and major product lines was as follows (dollars in thousands):

Three-Months Ended June 30, Change
2021 2020 $ %
Net sales:
Direct net sales:
Cardio products(1)
$ 31,430 $ 45,585 $ (14,155) (31.1) %
Strength products(2)
31,966 4,848 27,118 559.4 %
Direct 63,396 50,433 12,963 25.7 %
Retail net sales:
Cardio products(1)
89,924 49,011 40,913 83.5 %
Strength products(2)
30,560 13,937 16,623 119.3 %
Retail 120,484 62,948 57,536 91.4 %
Royalty 713 807 (94) (11.6) %
$ 184,593 $ 114,188 $ 70,405 61.7 %
Cost of sales:
Direct $ 38,882 $ 22,910 $ 15,972 69.7 %
Retail 90,206 43,882 46,324 105.6 %
$ 129,088 $ 66,792 $ 62,296 93.3 %
Gross profit:
Direct $ 24,514 $ 27,523 $ (3,009) (10.9) %
Retail 30,278 19,066 11,212 58.8 %
Royalty 713 807 (94) (11.6) %
$ 55,505 $ 47,396 $ 8,109 17.1 %
Gross margin:
Direct 38.7 % 54.6 % (1,590) basis points
Retail 25.1 % 30.3 % (520) basis points
Contribution:
Direct $ 6,759 $ 16,995 (10,236) (60.2) %
Retail 22,090 11,613 10,477 90.2 %
Contribution rate:
Direct 10.7 % 33.7 % (2,300) basis points
Retail 18.3 % 18.4 % (10) basis points
(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, Bowflex® VeloCore®, Schwinn® IC4, Max Trainer®, connected-fitness treadmills, other exercise bikes, ellipticals and subscription services.
(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories.


	Three-Months Ended June 30,						Change
	2022			2021			$			%
Net sales:
Direct net sales:
Cardio products(1)	$	17,133		$	31,430		$	(14,297)		(45.5)	%
Strength products(2)	9,343			31,966			(22,623)			(70.8)	%
Direct	26,476			63,396			(36,920)			(58.2)	%

Retail net sales:
Cardio products(1)	$	11,843		$	89,924		$	(78,081)		(86.8)	%
Strength products(2)	15,601			30,560			(14,959)			(48.9)	%
Retail	27,444			120,484			(93,040)			(77.2)	%



Royalty	897			713			184			25.8	%
	$	54,817		$	184,593		$	(129,776)		(70.3)	%

Cost of sales:
Direct	$	21,914		$	38,882		$	(16,968)		(43.6)	%
Retail	25,946			90,206			(64,260)			(71.2)	%

	$	47,860		$	129,088		$	(81,228)		(62.9)	%

Gross profit:
Direct	$	4,562		$	24,514		$	(19,952)		(81.4)	%
Retail	1,498			30,278			(28,780)			(95.1)	%
Royalty	897			713			184			25.8	%
	$	6,957		$	55,505		$	(48,548)		(87.5)	%
Gross profit margin:
Direct	17.2		%	38.7		%	(2,150)		basis points
Retail	5.5		%	25.1		%	(1,960)		basis points

Contribution:
Direct	$	(9,893)		$	6,759		$	(16,652)		(246.4)	%
Retail	(5,408)			22,090			(27,498)			(124.5)	%

Contribution rate:
Direct	(37.4)		%	10.7		%	(4,810)		basis points
Retail	(19.7)		%	18.3		%	(3,800)		basis points

(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, VeloCore®, Schwinn® IC4, Max Trainer®,connected-fitness treadmills, other exercise bikes, ellipticals andsubscription services.

(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories.

Table of Contents

Sales and Gross Profit

Direct Segment

Comparison of Segment Results for the Three-Month Period Ended June 30, 2022 to the Three-Month Period Ended June 30, 2021

Net sales were $26.5 million for the ~~three-months~~three-month period ended June 30, ~~2021 were~~2022, compared to $63.4 million, a decline of 58.2%, versus the same period in 2021, and up ~~25.7%, from $50.4~~27.1% compared to the same period in fiscal 2020. Net sales decrease was primarily driven by the return to pre-pandemic seasonal demand and higher sales discounting.

Cardio sales declined 45.5% versus the same period in 2021, and were up 6.5% compared to the same period in fiscal 2020. Lower cardio sales this quarter were primarily driven by lower bike demand. Strength product sales declined 70.8% versus the same period in 2021, and increased 96.7% compared to the same period in fiscal 2020. Lower strength sales this quarter were primarily driven by lower demand for SelectTech® weights.

The Direct segment ended the quarter with $0.4 million inof backlog as of June 30, 2022, as product demand has declined compared the same period last year. These amounts represent unfulfilled consumer orders net of current promotional programs and sales discounts.

~~Strength product sales grew 559.4% to a historical record, led by the popular SelectTech~~® ~~weights and Bowflex~~® ~~Home Gyms. Cardio sales declined 31.1%, primarily due to end-of-life products that are no longer available for sale this year and a decline in sales of the Schwinn~~® ~~IC4 Bowflex~~® ~~C6 bikes that~~Gross profit margin was ~~partially offset by VeloCore~~® ~~sales.~~

~~Gross margin rate~~17.2% for the ~~three-months~~three-month period ended June 30, ~~2021 was~~2022 versus 38.7%~~, down 15.9%, from 54.6% in~~ for the same period ~~last year.~~in 2021. The ~~15.9~~21.5 ppt decrease in gross margin was primarily driven by: ~~higher landed product costs (-6~~

~~Table of Contents~~

increased discounting (-8 ppts), ~~higher outbound freight costs (-6~~unfavorable logistics overhead absorption (-7 ppts)~~, deleveraging of fixed costs as direct sales grew slower than retail’s (-2 ppts), a strategic decision to end production of select SKUs (-1 ppt)~~, and increased investments in JRNY®~~(-1 ppt)~~ (-7 ppts). Gross profit was ~~$24.5~~$4.6 million, down ~~10.9%~~81.4% versus ~~last year. Gross profit for~~ the ~~three-months ended June 30, 2021 was $24.5 million, down 10.9% compared to gross profit of $27.5 million~~ same period ~~last year.~~in 2021.

Segment contribution ~~income~~loss was $9.9 million for the ~~three-months~~three-month period ended June 30, ~~2021 was $6.8 million or 10.7%, down 60.2%,~~2022, compared to segment contribution income of ~~$17.0~~$6.8 million ~~or 33.7%~~ for the same period ~~last year.~~in 2021. The ~~$10.2 million~~ decline was primarily driven by lower gross profit, ~~and the return to normalized levels of~~as explained above, offset by decreased media spend. Advertising expenses were $5.2 million compared to $8.0 million for the ~~three-months ended June 30, 2021 compared to $2.4 million last year.~~same period in 2021.

Combined consumer credit approvals by our primary and secondary U.S. third-party financing providers for the ~~three-months~~three-month period ended June 30, ~~2021~~2022 were ~~53.0%~~53.8%, compared to ~~48.4% in~~53.0% for the same period ~~of 2020.~~in 2021. The increase in ~~approval rates~~approvals reflects higher credit quality applications.

Retail Segment

~~Retail segment sales~~

Comparison of ~~$120.5 million~~Segment Results for the ~~three-months ended~~Three-Month Period Ended June 30, ~~2021,~~2022 to the ~~best quarterly sales in segment history.~~Three-Month Period Ended June 30, 2021

Net sales for the ~~three-months~~three-month period ended June 30, ~~2021~~2022 were ~~up 91.4%~~$27.4 million, down 77.2%, from ~~$62.9~~$120.5 million for the same period ~~last year, or 120.7% excluding~~in 2021. Excluding sales related to Octane, net sales were down 2% compared to the ~~Octane brand.~~same period in fiscal 2020. Retail segment sales outside the United States and Canada ~~grew 70%, or 102% excluding Octane.~~were down 83.4% versus last year. The decrease in sales compared to last year is primarily driven by lower cardio sales and higher sales discounting as Retailers work through higher than normal inventory levels.

Cardio sales for the three-month period ended June 30, 2022 decreased by 86.8%. Excluding sales related to Octane, cardio sales were down 28.7% compared to the same period in fiscal 2020. Strength product sales ~~grew~~declined by ~~119.3%,~~48.9% versus last year. Strength sales were up 36.8% compared to the same period in fiscal 2020, led by ~~our~~the popular ~~SelectTech~~® ~~weights and benches and Bowflex~~® ~~Home Gyms. Cardio~~SelectTech® weights. The decrease in sales ~~increased by 83.5%,~~compared to ~~a historical record,~~last year is primarily driven by ~~connected-fitness bikes~~lower bike sales and ~~treadmills.~~higher sales discounting as Retailers work through higher than normal inventory levels.

~~Gross margin rate for~~As of June 30,2022, the ~~three-months ended June 30, 2021 was 25.1%, down from 30.3% in~~Retail segment's backlog totaled $48.0 million, as retailers are now ordering closer to time of need compared to the same period last year. These amounts represent customer orders for future shipments and are net of contractual rebates and consideration payable to applicable Retail customers.

Gross profit margins were 5.5% for the three-month period ended June 30, 2022, down from 25.1% for the same period in 2021. The ~~5.2~~19.6 ppt decrease in gross margin was primarily driven by: ~~higher landed product costs (-6~~increased discounting (-11 ppts), and unfavorable logistics overhead absorption (-9 ppts). Gross profit was $1.5 million, a ~~strategic decision to end production~~decrease of ~~select SKUs (-1 ppt), offset by leverage on fixed costs as retail segment sales grew faster than direct segment sales (+2 ppts).Gross profit~~95.1% versus the same period in 2021.

Table of Contents

Segment contribution loss for the ~~three-months~~three-month period ended June 30, ~~2021~~2022 was ~~$30.3~~$5.4 million, ~~an increase~~or 19.7% of ~~58.8%~~sales, compared to ~~gross profit of $19.1 million same period last year.~~

~~Segment~~segment contribution income ~~for the three-months ended June 30, 2021 was~~of $22.1 million, or 18.3%~~, compared to $11.6 million or 18.4%~~ of sales for the same period ~~last year,~~in 2021, primarily driven by ~~higher~~lower gross profit ~~and expense leverage.~~as explained above.

Royalty

Royalty income increased by $0.2 million, or 25.8%, to $0.9 million for the three-month period ended June 30, 2022, compared to the same period of 2021, primarily due to royalty settlements.

Selling and Marketing

Selling and marketing expenses include payroll, employee benefits, and other headcount-related expenses associated with sales and marketing personnel, and the costs of media advertising, promotions, trade shows, seminars, sales incentives related to our JRNY® platform and other programs.

Selling and marketing information was as follows (dollars in thousands):


		Three-Months Ended June 30,		Change			Three-Months Ended June 30,						Change
		2021	2020	$	%		2022			2021			$		%
Selling and marketing	Selling and marketing	$21,300	$12,446	$8,854	71.1%	Selling and marketing	$	12,891		$	21,300		$	(8,409)	(39.5)%
As % of net sales	As % of net sales	11.5%	10.9%			As % of net sales	23.5		%	11.5		%

The ~~increase~~decrease in selling and marketing ~~expense in~~expenses for the three-month period ended June 30, ~~2021 as~~2022 compared to the same period of ~~2020~~2021 was primarily related to a ~~$5.6~~decrease of $5.7 million ~~increase~~ in ~~Direct~~ media ~~advertising~~spend and a ~~$3.1~~decrease of $2.7 million ~~increase for brand marketing.~~in other variable selling and marketing expenses due to decreased sales. We expect variable selling and marketing expenses to continue to flex with sales.

Media advertising expense ~~of our Direct business~~ is the largest component of selling and marketing and was as follows (dollars in thousands):


	Three-Months Ended June 30,				Change
	2022		2021		$		%


Total advertising	$	5,120	$	10,824	$	(5,704)	(52.7)%

~~Table of Contents~~

Three-Months Ended June 30, Change
2021 2020 $ %
Media advertising $8,016 $2,385 $5,631 236.1%
As % of net sales 4.3% 2.1%

The ~~increase~~$5.7 million decrease in media advertising expense for the three-month period ended June 30, ~~2021~~2022, as compared to the same period of ~~2020 was primarily due the~~2021 reflects a return to ~~normalized~~more historical, pre-pandemic levels of ~~media spend.~~advertising support to preserve market share and control costs. Advertising as a percentage of selling and marketing for the three-month period ended June 30, 2022 was 39.7% as compared to 50.8% for the same quarter last year and 37.2% for the same period in fiscal 2020.

General and Administrative

General and administrative expenses include payroll, employee benefits, stock-based compensation expense, and other headcount-related expenses associated with ~~the executive team,~~ finance, legal, ~~IT,~~ facilities, certain human resources and other administrative personnel, and other administrative fees.

General and administrative ~~expenses~~ was as follows (dollars in thousands):


		Three-Months Ended June 30,		Change			Three-Months Ended June 30,						Change
		2021	2020	$	%		2022			2021			$		%
General and administrative	General and administrative	$11,523	$9,315	$2,208	23.7%	General and administrative	$	12,463		$	11,523		$	940	8.2%
As % of net sales	As % of net sales	6.2%	8.2%			As % of net sales	22.7		%	6.2		%

~~General~~Table of Contents

The increase in general and administrative expenses ~~were~~ ~~higher~~ for the ~~three-months~~three-month period ended June 30, ~~2021~~2022 compared to the same period of ~~2020~~2021 was primarily ~~driven by~~due to increases in ~~IT, and for short-term incentive and~~ personnel costs.

Research and Development

Research and development expenses include payroll, employee benefits, other headcount-related expenses and information technology associated with product development.

Research and development ~~expenses were~~was as follows (dollars in thousands):


		Three-Months Ended June 30,		Change			Three-Months Ended June 30,						Change
		2021	2020	$	%		2022			2021			$		%
Research and development	Research and development	$4,815	$3,728	$1,087	29.2%	Research and development	$	5,823		$	4,815		$	1,008	20.9%
As % of net sales	As % of net sales	2.6%	3.3%			As % of net sales	10.6		%	2.6		%

The increase in research and development expenses for the three-month period ended June 30, ~~2021~~2022, as compared to the same period of ~~2020~~2021, was driven primarily ~~driven~~ by ~~an increase~~increased investments in ~~investment for our digital platform~~ JRNY®, ~~which more than offset savings associated with the divestiture of Octane.~~our digital platform.

~~Loss on Disposal Group~~Goodwill and Intangible Impairment Charge

In accordance with ASC 350 — Intangibles — Goodwill and Other, we perform a goodwill and indefinite-lived asset impairment evaluation during the fourth quarter of each year. However, as a result of the decline in our market value relative to the market and our industry, which was identified as a triggering event, we performed an interim evaluation and a market capitalization reconciliation during the first quarter of fiscal 2023, which resulted in a non-cash goodwill and indefinite-lived intangible assets impairment charge of $27.0 million.

ASC 350 requires us to make significant assumptions and estimates about the extent and timing of future cash flows, discount rates, growth rates and terminal value. The cash flows are estimated over a significant future period of time, which makes those estimates and assumptions subject to an even higher degree of uncertainty. We also use market valuation models and other financial ratios, which require us to make certain assumptions and estimates regarding the applicability of those models to our assets and businesses.

In accordance with ASC 360 — Property, Plant, and Equipment and other long-lived assets, we perform a test for recoverability when triggering events occur. No impairment was recognized in the quarter ended June 30, ~~2020, we recorded a $29.0 million non-cash charge related to the fair value of the held-for-sale of assets of our Octane Fitness brand name which was sold in October 2020.~~2022.

~~Interest Expense~~For additional information related to our goodwill and intangible impairment charge, see Note 7

~~Interest expense~~

Operating (Loss) Income

Operating loss for the three-months ended June 30, 2022 was ~~nearly flat at $0.3~~$51.2 million, a decrease of $69.1 million, or 386.5%, as compared to an operating income of $17.9 million for the ~~three-month~~same period ~~ended June 30, 2021~~of 2021. The decrease was primarily driven by a goodwill and ~~June 30, 2020.~~intangible impairment charge of $27.0 million and lower gross profit associated with lower sales and lower gross margins during the period.

Other, Net

Other, net ~~primarily~~ relates to the effect of exchange rate fluctuations ~~between~~with the U.S. and our foreign ~~subsidiaries and foreign exchange derivative contracts.~~subsidiaries.

Income Tax Expense ~~(Benefit)~~

Income tax ~~provision~~expense includes U.S. and international income taxes, and interest and penalties on uncertain tax positions.

Income tax expense ~~(benefit)~~ was as follows ~~(dollars in~~(in thousands):

2529

Table of Contents


		Three-Months Ended June 30,		Change			Three-Months Ended June 30,						Change
		2021	2020	$	%		2022			2021			$		%
Income tax expense (benefit)		$3,438	$(2,342)	$5,780	(246.8)%
Income tax expense						Income tax expense	$	8,096		$	3,438		$	4,658	135.5%
Effective tax rate	Effective tax rate	19.7%	32.0%			Effective tax rate	(15.5)		%	19.7		%

Income tax expense for the three-months ended June 30, 2022 was primarily a result of the U.S. deferred tax asset valuation allowance in the amount of $14.2 million recorded during the period. Income tax expense for the three-months ended June 30, 2021 was primarily driven by the profit generated in the U.S.

The ~~income~~effective tax ~~expense~~rate from continuing operations for the ~~three-months~~three-month period ended June 30, 2022, was primarily as a result of the aforementioned U.S deferred tax asset valuation allowance to reduce the existing U.S domestic deferred tax assets to their anticipated realizable value.

The effective tax rate from continuing operations for the three-month period ended June 30, 2021 was a result of the profit generated in the ~~U.S. The reduced effective tax rate for the same period was primarily due to~~U.S offset by the excess tax benefit related to stock-based ~~compensation recognized as a current period benefit through the Condensed Consolidated Statements of Operations.~~compensation.

~~The income tax benefit and effective tax rate~~(Loss) Income from Continuing Operations

Loss from continuing operations was $60.2 million for the ~~same period~~three-months ended June 30, 2022, or $(1.92) per diluted share, compared to income from continuing operations of $14.0 million, or $0.43 per diluted share, for the ~~prior year were~~three-months ended June 30, 2021. The decrease in income from continuing operations was primarily due to ~~the loss recorded~~lower gross profit and higher operating expenses as ~~a result of the held-for-sale valuation of our Octane Fitness disposal group~~discussed in ~~the quarter.~~more detail above.

Net (Loss) Income

Net loss was $60.2 million for the three-months ended June 30, 2022, compared to net income of $13.9 million for the three-months ended June 30, 2021. Net loss per diluted share was $(1.92) for the three-months ended June 30, 2022, compared to net income per diluted share of $0.43 for the three-months ended June 30, 2021.

Table of Contents

LIQUIDITY AND CAPITAL RESOURCES

Our future capital requirements may vary materially from those currently planned and will depend on many factors, including our levels of revenue, the timing and extent of spending on research and development efforts and other business initiatives, the expansion of sales and marketing activities, the timing of new product introductions, market acceptance of our products, and overall economic conditions. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing. The sale of additional equity would result in additional dilution to our shareholders. The incurrence of debt financing would result in debt service obligations and the instruments governing such debt could provide for operating and financing covenants that would restrict our operations.

As of June 30, ~~2021,~~2022, we had ~~$82.8~~$8.7 million of cash, cash equivalents and restricted cash, and ~~available-for-sale securities, and $53.6~~$35.1 million was available for borrowing under the ABL Revolving Facility, compared to ~~$113.2~~$14.2 million of cash, cash equivalents and restricted cash, and ~~available-for-sale securities, and $54.4~~$65.8 million ~~was~~ available for borrowing under the ABL Revolving Facility as of March 31, ~~2021.~~2022. We expect our cash, cash equivalents, restricted cash and ~~investments and~~ amounts available for borrowing under our ~~Wells Fargo Financing~~Credit Facility as of June 30, ~~2021,~~2022, along with cash expected to be generated from operations, to be sufficient to fund our operating and capital requirements for at least twelve months from June 30, ~~2021.~~2022.

Cash used in operating activities was $6.0 million for the three-month period ended June 30, 2022, compared to cash used in operating activities of $28.2 million for the three-month period ended June 30, ~~2021, compared to cash provided in operating activities of $40.2 million for the three-month period ended June 30, 2020.~~2021. The decrease in cash flows from operating activities for the three-month period ended June 30, ~~2021~~2022 as compared to the same period of ~~2020~~2021 was primarily due to changes in our operating assets and liabilities discussed below, ~~partially~~ offset by the ~~increase~~decrease in net income.

Trade receivables ~~increased by $9.5 million~~decreased to ~~$98.2~~$27.5 million as of June 30, ~~2021,~~2022, compared to ~~$88.7~~$61.5 million as of March 31, ~~2021,~~2022, primarily was due to ~~timing of customer payments on increased sales. Trade receivables as of June 30, 2021 compared to June 30, 2020 increased by $64.4 million due to~~lower sales and the timing of customer ~~payments on increased sales.~~payments.

Inventory was ~~$111.1~~$103.9 million as of June 30, 2022, compared to ~~$68.1~~$111.2 million as of March 31, ~~2021.~~2022. The ~~increase~~decrease in inventory iswas driven by ~~the~~sell-through and strategic ~~decision to increase~~demand planning as we balance on-hand inventory levels ahead of the fitness ~~season given continued disruption in global logistics. More than 60%~~season. About 8% of inventory as of June 30, ~~2021~~2022 was in-transit. ~~Inventories as of June 30, 2021 compared to June 30, 2020, increased by $89.8 million, primarily due to the surge in demand for home-fitness products.~~

Prepaid and other current assets decreased by ~~$10.2~~$2.6 million to ~~$15.7~~$12.0 million, compared to ~~$25.8~~$14.5 million as of March 31, ~~2021,~~2022, primarily ~~related~~due to ~~other short-term deposits for inventory.~~decreases in prepaid marketing and prepaid insurance.

Trade payables ~~increased~~decreased by ~~$15.7~~$26.4 million to ~~$114.6~~$26.8 million as of June 30, ~~2021,~~2022, compared to ~~$98.9~~$53.2 million as of March 31, ~~2021,~~2022, primarily due to timing of payments for inventory.

Accrued liabilities decreased by ~~$5.1~~$5.0 million to ~~$14.5~~$24.4 million as of June 30, ~~2021,~~2022, compared to ~~$19.6~~$29.4 million as of March 31, ~~2021,~~2022, primarily due to ~~deferred revenue liabilities.~~

~~Table~~decreases in accrued off-site materials of ~~Contents~~

$2.8 million and decreases in accrued personnel expenses of $1.2 million.

Cash ~~provided by~~used in investing activities of ~~$15.3~~$3.4 million for the three-month period ended June 30, ~~2021~~2022 was primarily due to ~~proceeds from sales and maturities of available-for-sale securities.~~capital purchases related to our digital platform. We anticipate spending between $12.0 million and $14.0 million in ~~2022~~fiscal 2023 for digital platform enhancements, systems integration, and production tooling.

Cash ~~used in~~provided by financing activities of ~~$1.1~~$7.1 million for the three-month period ended June 30, ~~2021~~2022 was primarily related to ~~tax~~proceeds from long-term debt offset by payments ~~related to stock award issuances.~~on long-term debt.

Table of Contents

Financing Arrangements

As of June 30, 2021, outstanding borrowings, net of debt issuance costs, totaled $13.4 million, with $11.9 million and $1.5 million under our Term Loan Facility and ABL Revolving Facility, respectively. As of June 30, 2021, we were in compliance with the financial covenants of the Credit Agreement and $53.6 million was available for borrowing under the ABL Revolving Facility. Any outstanding balance is due and payable on January 31, 2025.

Off-Balance Sheet Arrangements

We have long lead times for inventory purchases and, therefore, must secure factory capacity from our vendors in advance. As of June 30, ~~2021,~~2022, we had ~~approximately $174.9~~approximately $34.5 million,, compared to ~~$216.3~~$39.8 million as of March 31, ~~2021~~2022 in ~~non-cancelable~~non-cancellable market-based purchase obligations, primarily to secure additional factory capacity for inventory purchases in the next twelve months. Purchase obligations can vary from quarter-to-quarter and versus the same period in prior years due to a number of factors, including the amount of products that are shipped directly to Retail customer warehouses versus through Nautilus warehouses. The decrease in purchase obligations was primarily due to seasonality.

In the ordinary course of business, we enter into agreements that require us to indemnify counterparties against third-party claims. These may include: agreements with vendors and suppliers, under which we may indemnify them against claims arising from our use of their products or services; agreements with customers, under which we may indemnify them against claims arising from their use or sale of our products; real estate and equipment leases, under which we may indemnify lessors against third-party claims relating to the use of their property; agreements with licensees or licensors, under which we may indemnify the licensee or licensor against claims arising from their use of our intellectual property or our use of their intellectual property; and agreements with parties to debt arrangements, under which we may indemnify them against claims relating to their participation in the transactions.

The nature and terms of these indemnifications vary from contract to contract, and generally a maximum obligation is not stated. We hold insurance policies that mitigate potential losses arising from certain types of indemnifications.

~~Table of Contents~~

Management does not deem these obligations to be significant to our financial position, results of operations or cash flows, and therefore, no liabilities were recorded at June 30, ~~2021.~~2022.

SEASONALITY

~~Prior to the COVID-19 pandemic,~~We expect our revenue from fitness equipment products ~~varied~~to vary seasonally. Sales ~~were~~are typically strongest in ~~the~~our fiscal third quarter ending December and fiscal fourth ~~calendar~~ quarter ending March and ~~lowest~~are generally weakest in ~~the~~our fiscal first quarter ending June and fiscal second ~~calendar~~ quarter ~~as we~~ending September. We believe that consumers tend to be involved in outdoor activities during the spring and summer months, including outdoor exercise, which impacts sales of indoor fitness ~~equipment this~~equipment. This seasonality ~~had~~can have a significant effect on our inventory levels, working capital needs and resource utilization. ~~Since 2020, due to stay-at-home orders related to the COVID-19 pandemic, we did not experience the typical seasonality.~~

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our critical accounting policies have not changed other than goodwill from those discussed in our ~~2020~~fiscal 2022 Form 10-K.

Table of Contents

NEW ACCOUNTING PRONOUNCEMENTS

See Note 1 of Notes to Condensed Consolidated Financial Statements included in Part I, Item 1 for a discussion of ~~new~~recent accounting pronouncements.

2833

Table of Contents

Item 3. Quantitative and Qualitative Disclosures About Market Risk

~~Interest Rate and Foreign Exchange Risk~~

~~Our exposure to~~There have been no material changes in our market risk ~~from changes~~as compared to the disclosures in interest rates relates primarily to our cash equivalents, derivative assets and variable-rate debt obligations. Our cash equivalents mature within three-months or less from the date of purchase. Marketable securities with original maturities of greater than three-months and remaining maturities of less than one year are classified as short-term investments. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such marketable securities represent the investment of cash that is available for current operations. We have classified our marketable securities as available-for-sale and, therefore, we may choose to sell or hold them as changes in the market occur. Because of the short-term nature of the instrumentsPart II, Item 7A in our ~~portfolio, a decline in interest rates would reduce our interest income over time, and an increase in interest rates may negatively affect~~Annual Report on Form 10-K for the ~~market price or liquidity of certain securities within~~year ended March 31, 2022, filed with the ~~portfolio.~~

~~Our negotiated credit facilities generally charge interest based~~SEC on ~~a benchmark rate such as LIBOR. Fluctuations in short-term interest rates may cause interest payments on term loan principal and drawn amounts on the revolving line to increase or decrease. As of~~ June ~~30, 2021, the outstanding balances on our credit facilities totaled $13.7 million.~~

We enter into foreign exchange forward contracts to offset the earnings impacts of exchange rate fluctuations on certain monetary assets and liabilities. Total notional amounts outstanding as of June 30, 2021 we~~re $66.0 million.~~

A hypothetical 10% increase in interest rates, or a 10% movement in the currencies underlying our foreign currency derivative positions, would have material impacts on our results of operations, financial position or cash flows. We do not enter into derivative instruments for any purpose other than to manage our interest rate or foreign currency exposure. That is, we do not engage in interest rate or currency exchange rate speculation using derivative instruments.3, 2022.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

In accordance with Rule 13a-15 of the ~~Securities~~Securities Exchange Act of 1934, as amended (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Principal Executive Officer, ~~and our~~ Principal Financial Officer and Principal Accounting Officer, the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, our management, including the Principal Executive Officer, ~~and~~ Principal Financial Officer, and Principal Accounting Officer, have concluded that our disclosure controls and procedures were effective as of the end of the period covered by this report, our disclosure controls and procedures are effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the requisite time periods specified in the applicable Securities and Exchange Commission rules and forms, and that it is accumulated and communicated to our management, including our Principal Executive Officer ~~and~~ Principal Financial Officer, and Principal Accounting Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting that occurred during the three-months ended June 30, ~~2021,~~2022, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

During the quarter ended September 30, 2022, we recorded a $4.7 million loss contingency related to a legal settlement involving a class action lawsuit related to advertisement of our treadmills. The settlement includes damages, a one-year free membership to JRNY, and administrative fees and was included as a component of General and administrative on our Condensed Consolidated Statements of Operations for the fiscal year ended March 31, 2022. As of June 30, 2022, $4.6 million remained accrued and was reflected in Accrued liabilities on our Condensed Consolidated Balance Sheets. We expect to pay the settlement damages and related administrative fees during the second fiscal quarter of fiscal 2023.

On June 27, 2022, the Court approved the settlement and no appeals were filed. We expect to fund the common fund prior to our next quarter ending September 30, 2022.

As of the date of filing of this Quarterly Report on Form 10-Q, we were not involved in any material legal proceedings.

Item 1A. Risk Factors

We operate in an environment that involves a number of risks and uncertainties. The risks and uncertainties described in our ~~2020~~2022 Form 10-K are not the only risks and uncertainties to which we are subject, and there may be other risk and uncertainties that ~~presently~~ are not currently considered material or are not known to us ~~and therefore are not mentioned herein, may~~that could impair our business or operations. If any of the risks described in our ~~2020~~2022 Form 10-K actually occur, our business, operating results and financial position could be adversely affected. There ~~has not~~have been ano material ~~change~~changes to the risk factors as set forth in our ~~2020~~2022 Form 10-K.

Table of Contents

Item 6. Exhibits

The following exhibits are filed herewith and this list is intended to constitute the exhibit index:


Exhibit No.						Description

3.1						Amended and Restated Articles of Incorporation - Incorporated by reference to Exhibit A to Schedule 14A, as filed with the Commission on April 22, 2008.

3.2						Amended and Restated Bylaws - Incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, as filed with the Commission on April 5, 2005.

3.3						Amendment to Amended and Restated Bylaws of the Company - Incorporated by reference to Exhibit 3.1 of our Current Report on Form 8-K, as filed with the Commission on January 31, 2007.



~~10.1~~						~~Second Amendment to Credit Agreement dated May 13, 2021, by and between Nautilus, Inc. and Wells Fargo Bank, National Association~~
10.2*						~~Employment Agreement dated August 2, 2021, by and between Nautilus, Inc. and Alan L. Chan.~~
31.1						Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

31.2						Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.

32.1						Certification of Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities and Exchange Act of 1934, as amended, and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS						XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH						XBRL Taxonomy Extension Schema Document

101.CAL						XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF						XBRL Taxonomy Extension Definition Linkbase Document

101.LAB						XBRL Taxonomy Extension Label Linkbase Document

101.PRE						XBRL Taxonomy Extension Presentation Linkbase Document

* Indicates management contract, compensatory agreement or arrangement, in which our directors or executive officers may participate.

3036

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	NAUTILUS, INC.
	(Registrant)

August 9, ~~2021~~2022	By:	/S/ James Barr IV
Date		James Barr IV
		Chief Executive Officer


	NAUTILUS, INC.
	(Registrant)

August 9, ~~2021~~2022	By:	/S/ Aina E. Konold
Date		Aina E. Konold
		Chief Financial Officer

3137


	As of
	June 30,		March 31,
Assets:	2021		2021
Direct	$	45,176	$	47,002
Retail	192,189		146,001
Unallocated corporate	145,021		161,227
Total assets	$	382,386	$	354,230